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Abstract
In a situation where the number of available covariates greatly exceeds the num-
ber of observations, the fitting of a regression model to explain the connection
between the response and the explanatory variables can be a challenging task.
The problem can be compared to a set of equations with more unknowns than
there are equations and requires application of a regularisation method to result
in a useful solution. There are several such methods, with different properties.
This thesis focuses on one such method: the Lasso in combination with cross-
validation (CV) to determine the level of regularisation. Specifically, we consider
the method when applied on survival data where the covariates are thousands of
gene expression levels.
The combination of Lasso and CV proves to be unstable in the sense that
repeated application of the standard R implementation often give varying results.
This study’s main focus is to investigate what the causes of this instability may
be.
Data was simulated to map the factors that affect the stability. The simulated
data sets’ properties are easy to control and the effects on the regularisation
results are easily observed.
The tests show that the CV process cause marked instability (varying results)
when the division into training and test sets involve test sets with size larger than
one. Moreover, the stability of the regularisation depends on the properties of
the data set.
A unique prediction result is preferable to easily choose a prognostic gene
signature. However, a range of signatures from repeated regularisations can be
utilised to indicate the accuracy of the suggested signature.
This thesis maps several factors that affect the stability of Lasso and CV, and
will hopefully contribute to caution - be a warning flag - when utilising the Lasso
method to find a prognostic model.
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Chapter 1
Introduction
Both scientists and non-scientists are fascinated by the blueprint of life, our
DNA. The information stored in the DNA tells much about you beyond what is
visible on the surface. There are for example numerous conditions that have been
established as being completely or partially genetically determined, ranging from
rare diseases such as sickle-cell anemia, to common and harmless properties such
as baldness. Investigation of our genome, in order to reveal links between diseases
and the DNA, is important to be able to predict future illness. Furthermore, the
progress and response to a particular treatment may depend on the patient’s
genotype (the complete set of genes).
Some diseases, including cancer, are not normally hereditary, even though
they are genetically caused. A mutation may occur in a cell, e.g. because of
external factors such as radiation. All cells deriving from that cell will inherit the
mutation. Some mutations may be tumourigenic and increase the chance that
the cells multiply rapidly and uncontrolled, resulting in a tumour.
If a disease is completely or partially genetically determined, one faulty gene
or a larger group of genes may account for some of the reason. These genes
may be linked to each other, or they may be independent. Since genes (or gene
products) interact, a change in one gene may cause altered expression of several
genes; genes express themselves in mRNA (messenger RNA). The DNA string
of the gene is the recipe for a protein through protein synthesis. The messenger
that brings the recipe from the DNA string to the production of proteins is the
mRNA. The quantity of mRNA (and therefore also the protein product) for a
gene may vary over time and is referred to as the gene’s expression. (For more
motivation and introduction to biology, see Section 2.1.)
Changed expression levels may signal malignant changes. Humans have more
than 20,000 genes and there is usually a limited number of patients with the
illness or property in interest. The great number of genes compared to the number
of patients brings on a challenge for every biologist when trying to find features
separating malignant cells from healthy ones. Statistical methods may reduce the
number of candidate cancer genes until the few genes supposedly most relevant
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to the patient’s condition are left.
Several methods exist for this purpose. One, the Lasso method, reduces the
supposed significance of certain genes to zero such that a strict subset of genes is
left. Other methods, like ridge regression, reduces the supposed significance close
to zero, but not quite, such that it is harder to rule out which genes affect the
disease. The focus in this thesis is on the Lasso alternative because of the useful
variable selection property when coefficients are set to zero and because it is the
method of choice in a recent and well acknowledged paper[1]. In this paper the
Lasso is applied on colorectal cancer (CRC) data[1] and discusses which genes
make up a prognostic gene signature. The study concluded with a seemingly
useful answer, a prognostic 7-gene signature, despite the fact that the repeated
application of Lasso gave different answers. It also raised several questions:
• Why is the result so different when the input is identical every time? The
instability is worrying.
• Is the method dependent on details of the data set?
• Should other, or modified, methods be applied to verify the result?
In this thesis, the reader is thought of as a person with a certain interest and
understanding of basic statistic topics such as linear regression and probability
models. These topics are well explained in [2]. No prior knowledge about biology
or genetics is required to understand and find interest in the study. There will
be few biological details, but the necessary information will be explained.
1.1 Motivating example
Globally, about 1.2 million people are diagnosed with CRC and about 600,000 die
of the disease every year. It is the fourth most common cause of death by cancer,
more present in developed countries than in less developed countries[3].1 Four out
of five CRC patients are treated with surgery where the tumour is removed[5].
It is common to use cancer stage as a prediction for the success of treatment
of CRC[6]. This is an unreliable prediction, and it would be useful if genomic
data could be utilised to see if the patient is likely to respond well to treatment.
A paper published in 2012 by Sveen et al.[1] uses such data from 95 patients
to find a connection between treatment success and gene expression. Specifically,
a gene signature (i.e. a combination of genes) predicting the treatment result is
sought. The authors’ aim was to put the patients in a high risk group and in
a low risk group. The paper uses the R package penalized in order to do the
cross validation and Lasso regularisation. There is also another package called
1The disease is strongly correlated with a western diet consisting of e.g. red meat, fat and
alcohol[4].
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glmnet, which is applied on the same sort of problems as penalized, authored by
Friedman, Hastie and Tibshirani, the latter known for proposing the Lasso, see
Section 2.2.2. glmnet has been used among others by [7][8]. For more information
about the R packages, see Section 2.3.
When approaching the two methods with the same data and parameters, the
results may be different, as described below and in Section 3.1.
1.1.1 Rough summary of the method used in Sveen’s paper
Filtering. The data set used in the CRC paper[1] initially contains information
about the expression level of about 20,000 genes in 95 patients. Genes with
p-values from Cox regression greater than 0.5 or variance less than 0.2 were
considered non-interesting, see Figure 1.1. Such p-values suggest that the genes
linked to them probably are irrelevant to any difference between the patients.
Note that the null hypothesis here is that each gene is not relevant to the survival
of patients.
Similarly, low variance genes are unlikely to be relevant to the response. Con-
sequently, genes that differ between the patients are sought.
The R package penalized. After filtering based on variance and p-value,
Sveen et al.[1] were left with a little more than 3,000 genes. Starting with these
genes, the challenge was to end up with a predictive model with just a few
explanatory variables: the genes relevant to the response. In order to achieve
this, they used the optL1 function in the R package penalized. optL1 is an
implementation of the Lasso method, see Section 2.2.2 and can perform Cox
regression, as well as other types of regression.
Lasso. Lasso introduces a penalty parameter λ > 0 which decides how strict
the punishment is for including more genes in the model. Varying λ will vary the
number of genes included. The optL1 function basically works like this:
1. Divide the data in subsets, e.g. 10 groups of size 9-10 (95 patients in total).
2. For a fixed λ, use the Lasso on the data from all patients, except those from
one of the subsets to fit a (Cox) model.
3. Find the error on the excluded subset.
4. Repeat step 2 and 3 until all subsets have been removed once.
5. Sum the errors.
This process is called cross-validation (CV), see Section 2.2.7, and is repeated
on a sequence of reasonable λ-values. The λ that gave the smallest error is noted
and used to make a predictive model based on the complete data set.
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Figure 1.1: Flow of optL1. 1. The original gene set consisting of nearly
20,000 genes is filtered to include only those that vary the most amongst the
individuals and with small Cox p-values. 2. These are then run through CV and
the Lasso method 1000 times, taking note of the size of the supposedly relevant
gene signature (group) each time. 3. The result is presented using a bar diagram.
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Variation in results. Ideally, there is just one solution which concludes
with a suitable prediction model. However, for every new call to optL1 the result
varied, similarly to what is shown in Figure 1.2.
To obtain a conclusive answer, Sveen et al. repeated Lasso a thousand times
and took note of the signature size (the number of coefficients different from zero)
each time. Eight gene expression signatures of size zero to twelve showed up more
than fifty times each. These signatures were then run on a first validation series;
the five larger signatures were significant here. The 7-gene expression signature
gave a prognosis closest to the actual survival outcome. Note that the smaller
signatures were always contained in the larger ones. A third run on a second
validation series verified that the 7-gene signature gave a reasonable prognosis.
Reproduction. In the attempt to reproduce the results, the same recipe
was followed and nearly the same result was achieved. The seven genes that make
up the prognostic gene expression signature in the paper, are the same seven that
were left in the 7-gene signature in my calculations. There were fewer hits on the
7-gene signature, however. It was not the one with the most hits in the paper
either, but the next steps in [1] were used to justify the result.
Unstable Lasso results permeate my calculations, as well as those performed
by the paper’s authors. Thus, in this thesis, the reasons for instability are at-
tempted unraveled and an answer to the question “Is a result based on such Lasso
calculations reliable?” is sought.
1.2 Chapter overview
Chapter 2 gives a general introduction to the required biological and statistical
concepts. Lasso and CV have already been mentioned in the introduction, but
the motivation for choosing these methods and the theory behind them will be
given more attention there. Also, there is an introduction to the R packages
penalized and glmnet which performs Lasso regularisation and CV, as well as
other types of regularisation. Chapter 3 discusses the methods of investigation
and how to display the results. Data is simulated to mimic real data so that
the properties of the data set can be controlled and the effect of these can be
measured. Simulated data sets also ease the process of testing CV parameters
on different data sets. Chapter 4 presents the results from the investigations
described in Chapter 3. Then a conclusion on the question “Is the algorithm
described in Sveen et al.’s paper[1] reliable?” is approached. This is discussed in
Chapter 5. In Chapter 6 the results are further discussed and suggestions for
further work are presented.
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Figure 1.2: Signature size bar diagram. The numbers along the x-axis
are the sizes of the gene signatures (the number of genes included by Lasso).
The height of each bar describes the number of times a signature with the given
number of genes is found. The 0-, 1- and 2-signatures are the most frequent, but
the 8-, 10- 11- and 12-signatures are also interesting. Judging from this diagram,
obtained by the author (and deviating slightly from the one obtained by Sveen et
al.[1]), the signatures of size 3 to 7, 9 and larger than 12 are less likely to be of
any interest.
Chapter 2
Background
Genes, gene expression, mRNA and other biological terms were mentioned in the
introduction. In this chapter these terms are further explained. The statistical
terms Lasso, Cox, cross-validation, etc. are also described.
2.1 Biological background
The genetic material in humans is stored as 46 chromosomes: 22 pairs of non-
sex chromosomes (autosomes) and two sex chromosomes (XX for females and
XY for males)[9], see example of a chromosome map in Figure 2.1. Each chro-
mosome consists of a DNA molecule complexed with proteins and winds up to
form chromatin. Most DNA, about 97% in humans, is non-coding1. The rest
of the DNA is coding and form genes. A gene is a subset of the chromosome
DNA string and is the recipe of (a part of) a protein. The DNA string includes
nucleotides where each nucleotide includes one of the nucleobases guanine (G),
adenine (A), thymine (T) and cytosine (C). A DNA string is recognised by its
order of nucleobases.
Through protein synthesis, the gene is read and instructs the creation of a
protein. If a gene is missing, some proteins may not be made, or if the gene has
been altered from the original, a protein may function differently. In cancer, there
is a fault that promotes non-normal growth or reduces a cell’s ability to carry
out suicide (apoptosis) when malfunctioning. Usually, cells multiply and die in
balance, at varying speed in different part of your body. In fact, during a period
of a few years your whole body will consist of new cells, with some exceptions
such as the brain.
The translation of DNA to proteins happen via mRNA, messenger RNA.
mRNA is the complementary string of a DNA string (gene), i.e. the mRNA
have complementary nucleobases to the DNA string. The mRNA is the gene
1Non-coding DNA was earlier called ”junk DNA” because it was unclear if it had any bio-
logical function. However this has been disproved, and the term is no longer used.
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expression. Some genes provide many copies of mRNA, whereas other genes
generate few. This can vary between individuals and also over time in a cell. The
number of mRNAs from a gene is called the gene expression level.
A missing or incorrect gene is caused by a mutation. If the mutation causes
the creation of a tumour, the mutation is tumourigenic.
2.1.1 Data structure
In a gene expression study involving p genes and n individuals, the gene expression
levels may be expressed as an n× p matrix.
X =
gene 1 gene 2 . . . gene p
patient 1 4400 340 . . . 40
patient 2 4450 2 . . . 41
...
patient n 4349 358 . . . 43
(2.1)
The survival times of all observations may be expressed in a column vector:
(y1, y2, . . . , yn)
T = (8, 3, . . . , 10)T
For more information about survival times and other survival analysis terms see
Section 2.2.3.
Suppose the patients should be divided into two or more groups, for example
a high risk group and a low risk group. In the above example, gene 1 is expressed
at about the same level in patients 1, 2 and n, and say this is the case for patients
2,3, . . . , n − 1 as well. Then the gene most likely has nothing to do with the
response in interest. (It may have something to do with the survival time, but
it is the differences between the patients that are interesting. That way the
observations can be split into different groups which means that common factors
can be ignored.)
The difference in gene 2 is interesting however. The gene is hardly expressed
in patient 2, relative to patients 1 and n. It is now interesting to look upon:
• What is the normal gene expression level?
• Which patient(s) differ from this?
• Does it have anything to do with the response, or is the high/low gene
expression level harmless? Say that patient 2 did not survive as long as the
other patients. Can this be explained by the difference in gene 2?
Working with the CRC data[1], interesting gene expression levels are sought
to see if they are linked to the response. Can genes that predict the survival time
of the patient be found?
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Figure 2.1: Sketch of the protein synthesis. 1. Each chromosome contains
a long DNA string. 2. Some parts of the chromosome are called genes; they
code for proteins. 3. The gene (DNA substring) is transcribed to mRNA, a
complementary string. 4. The mRNA is translated to a protein consisting of a
chain of amino acids. Chromosome map from [10].
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2.2 Statistical background
Survival analysis is the underlying theme of this study. In survival analysis the
data set contains information about a set of patients: a number of covariates
(in our case the expression level of one of more genes), an observation time and
whether the observation time reflects time to a specific event (such as death) or
time to censoring (e.g. due to the subject being alive at the end of the study
period).
The challenge is to find out if there is a link between the covariates and
survival, and if so find the link. In order to perform the analysis, a presentation
of some statistical tools discussed follows in this section.
2.2.1 Introduction
A regression model is a way of explaining the connection between the covariates
and the response: in our case the gene expression levels and survival time. A
linear regression model looks like this
y = β0 + β1x1 + . . .+ βpxp +  = β0 + β
Tx+ . (2.2)
The y represents the response, e.g. some clinical variable measured on a con-
tinuous scale. The βis are the weights of the explanatory variables, the xs, e.g.
gene expression levels. Often, the β0 is included in β by adding an element, 1,
in x, making y = βTx+ .  is the error, or the noise term. When there is more
than one observation available, the βis can be estimated using the least squares
method.
2.2.2 The Lasso method
When dealing with genetic data there will often be information about many more
genes than observations, i.e. p >> n. The problem of fitting a regression model
such as the Cox model may then be compared to solving a system of equations
with more unknowns than equations, which makes it possible to choose the values
of the unknowns in infinitely different ways. If no precautions are taken, this
process may result in a fit adapted to the noise instead of, or in addition to, the
variables that are actually related to the response. The resulting model may be
overfitted, and will be useless for the prediction in a general case[11]. For further
motivation, see Section 2.2.7.
In order to settle on a few well-chosen variables, the explanatory variables
that are irrelevant to the response should be removed. There are several ways
to do this; some include shrinking the regression coefficients until they approach
zero, while others actually reduce them to zero. For more information, see Section
2.2.6. Lasso is one of the latter methods.
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Lasso
The Lasso (Least Absolute Shrinkage and Selection Operator) estimate for ordi-
nary continuous data is defined by[12][13]:
βˆ = minβ
N∑
i=1
(
yi − β0 −
p∑
j=1
xijβj
)2
, s.t.
p∑
j=1
|βj| ≤ t, (2.3)
where yi is response i and xij is the jth covariate of observation i. The difference
yi − β0 −
∑p
j=1 xijβj is actually the difference between the observed response
yi and the predicted response yˆi = β0 +
∑p
j=1 xijβj. So, the solution βˆ to the
problem, is the β that minimises the error, under the constraint
∑p
j=1 |βj| ≤ t.
By choosing t very large, there will be no constraint at all and the fit will
approach that of an ordinary linear regression model. But, by letting t→ 0 some
of the coefficients βj will move towards zero which is the intent. In the extreme
case of t = 0, the βjs will all be forced to be zero, and the model has no variables
with non-zero coefficients.
Notice that Lasso may be written in the Lagrangian form
βˆ = minβ
1
2
N∑
i=1
(
yi − β0 −
p∑
j=1
xijβj
)2
+ λ
p∑
j=1
|βj|
 . (2.4)
The solution to this is equivalent to (2.3) by application of the Lagrange multiplier
theorem[13]. Decreasing the t is the same as increasing the λ; λ → ∞ ⇔ t = 0
because a large λ penalty will lead the minimisation problem to choose βj = 0 for
all js such that the term λ
∑p
j=1 |βj| is as small as possible, zero. The problem,
λ = 0 ⇔ t → ∞, represents having no penalty at all. The term λ∑pj=1 |βj| is
called the L1 penalty.
To find βˆ, methods based on quadratic programming may be used[12]. They
are iterative, and in every iteration a least squares problem is solved.
There exists variations of Lasso, such as adaptive Lasso. The adaptive Lasso
method adds weights to the restrictions
∑p
j=1 |βj| ≤ t, so instead it becomes∑p
j=1 |βj|τj ≤ t, τj > 0 for all j. The choice of weights is very important, and
Zhang and Lu[14] propose using τj = 1/|β˜j|, which is just one of many possible
choices. They motivate the choice by the consistency of the β˜js; the β˜js reflect
the importance of the covariates.2
2.2.3 Survival analysis
Survival models in cancer usually describe the risk of death or relapse; from here
on death will be used as an example, as in [1]. The survival function is the
2|βj |/|β˜j | → I(βj 6= 0) = {1 when βj 6= 0; 0 when βj = 0} when n→∞.
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risk of death occurring later than a given time t:
S(t) = P (T > t), (2.5)
where T is a random variable representing time of death[15]. Note that the sur-
vival function S is decreasing, approaching zero as no person can live forever.
However, survival models may be applied in other areas such as mechanical en-
gineering where it makes more sense to talk about eternal life. Also, S(0) is
assumed to be 1, except if there is a chance of immediate event.
The hazard rate reflects the death intensity in a small time interval [t, t+dt),
given that the individual has survived up until the time t. Here dt is approaching
zero, so the hazard rate represents the instant death rate. This function is often
denoted λ:
λ(t) = lim
∆t→0
P (t ≤ T < t+ ∆t|T ≥ t)
∆t
(2.6)
which can be rewritten by following[13]:
P (t ≤ T < t+ ∆t|T ≥ t) = 1− P (T ≥ t+ ∆t|T ≥ t)
= 1− P (T ≥ t+ ∆t)
P (T ≥ t)
= 1− S(t+ ∆t)
S(t)
By putting both parts in the same fraction,
λ(t) = lim
∆t→0
1
∆t
· S(t)− S(t+ ∆t)
S(t)
= − 1
S(t)
lim
∆t→0
S(t+ ∆t)− S(t)
∆t
= −S
′(t)
S(t)
,
(2.7)
where the definition of the derivative S ′(t) = lim∆t→0(S(t+ ∆t)− S(t))/∆t was
applied in the last transition.
The relation between the hazard rate λ(t) and the survival function S(t) is
useful. By the chain rule, we know that d
dt
logS(t) = S ′(t)/S(t), and
λ(t) = −S
′(t)
S(t)
= − d
dt
logS(t), (2.8)
which implies that
S(t) = exp(−Λ(t)), Λ(t) =
∫ t
0
λ(s)ds. (2.9)
Λ(t) is called the cumulative hazard and it follows from (2.8) and (2.9) that
the relation between the cumulative hazard and the survival function is Λ(t) =
− logS(t).
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Another useful relation is that the lifetime distribution function F (t) describes
the negative survival function: F (t) = 1− S(t). By this, the density function is
f(t) = −S ′(t). This is the foundation of an equivalent version of the hazard rate:
λ(t) =
f(t)
S(t)
(2.10)
Survival models are based on survival data, i.e. information about a set of
observations, usually patients. This includes a censor indicator which tells you
if a patient has been withdrawn from the experiment for some reason. Death by
other causes than the illness of interest, a patient failing to turn up for check-ups
or voluntarily withdrawing from the experiment may all be causes for censoring.
Usually the events are denoted with ones and zeros: A one represents event
(death) and a zero represents censoring.
In addition to this information, there usually is information about gender, age,
gene expression levels, as described in Section 2.1, and the time until withdrawal
or event (death), called survival time. The survival time is usually the time from
the entering of the patient in the study until event or censoring. A patient may
be entered in a study at the time the tumour was discovered. Other survival
times, such as age, may also be applied.
2.2.4 The Cox model
The most common regression model for survival data is the Cox model because
it makes no assumptions about the baseline hazard λ0(t), it is semi-parametric,
as described in this section. According to this model, the hazard function is
λ(t|x1, . . . , xp) = λ0(t) exp(β1x1 + . . .+ βpxp)
or
λ(t|x) = λ0(t) exp(βTx). (2.11)
Here, x = (x1, . . . , xp) are the p covariates values for each individual. λ0(t) is
the baseline hazard. Notice that if β = 0, then λ(t|x) = λ0(t). Consider two
individuals with covariate vectors xa and xb. Then
λ(t|xa)
λ(t|xb) =
λ0(t) exp(β
Txa)
λ0(t) exp(β
Txb)
= exp
(
βT (xa − xb)
)
. (2.12)
Thus the ratio of the hazards of two individuals is independent of time. Suppose
the ith covariate increases by 1 and all other covariates are identical in the two
individuals, i.e. xa,i = xb,i + 1 and xa,k = xb,k for k 6= i. Then, by inserting into
(2.12):
λ(t|xa)
λ(t|xb) = exp(βi), (2.13)
which is called the hazard ratio for the ith covariate.
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The partial likelihood
It is a complicated task to estimate the regression coefficients β from the hazard
function (2.11) as it is a function of more than one parameter. Cox observed
that with the independence of time it is possible to estimate β without modelling
the hazard function, and instead maximise the partial likelihood[16]. This
approach is called Cox proportional hazards model[15].
The partial likelihood is a function of β:
L(β) =
∏
i:Ci=1
θi∑
j:Yj≥Yi θj
, θk = exp(β
Txk). (2.14)
where x1, . . . ,xn are the covariate vectors (column vectors) for the n observations,
each consisting of p covariates. Yk is the observed time for the kth individual and
is censored if Ck = 0. Ci = 1 means that individual i is non-censored, i.e. an
event has taken place. The notation δi ∈ {0, 1} is also common for censoring
status.
The partial likelihood is, in words: For all non-censored individuals i, multiply
the hazard ratio (for i) divided by the sum of the hazard ratios of all individuals
still alive at the time of event i (both censored and non-censored).
The log partial likelihood is given by
l(β) =
∑
i:Ci=1
(βTxi − log
∑
j:Yj≥Yi
θj) =
∑
i:Ci=1
ϕi(β), (2.15)
which we may maximise to find the maximiser of (2.14).
2.2.5 Lasso and the Cox model
So far, the general linear regression case of Lasso has been described. In Section
2.2.4, the Cox model was introduced which may also be combined with Lasso.
Tibshirani[16] proposes to estimate βˆ by
βˆ = argmaxβ l(β), s.t.
p∑
j=1
|βj| ≤ t, (2.16)
where l(β) is the log partial likelihood given in (2.15). To find βˆ, Tibshirani[16]
proposes to first fix t and initialise βˆ = 0, then minimise (z − η)TA(z − η),
where z, η and A are based on our existing knowledge of X, β = βˆ and l,
subject to
∑p
j=1 |βj| ≤ t through a quadratic programming procedure. Repeat
the minimisation until βˆ converges.
Tibshirani was not the first person to consider quadratic programming as a
solution to such a problem, or even representing the problem with an L1 penalty
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(Lasso). The first use of linear programming was by Leonid Kantorovich in 1939
who used it to plan effective moves in World War II.
A basic linear programming problem can look like this:
max f(x, y) = max(2x+ 3y), s.t. g(x, y) = 4x+ 0.5y ≤ 10, x, y ≥ 0. (2.17)
This problem can be solved by the simplex algorithm.
Application of the Lagrange multiplier theorem, as mentioned in Section 2.2.2,
can transform the problem into an equivalent problem:
Λ(x, y, λ) = f(x, y) + λ · (g(x, y)− c) = 2x+ 3y + λ(4x+ 0.5y − 10) (2.18)
The minimisation points (x, y) of this problem give the solution to (2.17). Note
that this is similar to the Lasso formulae in (2.3) and (2.4). The Lasso problem
forms a quadratic programming problem instead, because the function in (2.16)
is quadratic.
2.2.6 Other regularisation methods
The Lasso is not always the best choice. In a situation where variables are
correlated within groups, Lasso tends to pick one of these and discard the rest. A
proposed zero-coefficient therefore does not necessarily mean that the variable is
irrelevant; it could just be correlated with another variable which has a non-zero
coefficient.
In the case where p > n, i.e. the number of genes is greater than the number of
observations, Lasso includes a maximum of n (number of observations) variables.
Zou and Hastie[17] argue that this is a limiting feature of the method.
There are other methods that avoid these issues, such as ridge regression[18]
and the elastic net[17].
Ridge regression
Ridge regression maintains the number of variables in the model, it just shrinks
the coefficients. All the variables are included in the final model. However, it is
not necessarily easy to see which are more relevant to the survival response. The
coefficient sizes may say something, but must be seen in relation to the covariate
value. A large coefficient combined with a small covariate may make only a small
contribution to the overall predicted effect and vice versa.
The corresponding expression to (2.4) is:
βˆ = minβ
1
2
N∑
i=1
(
yi − β0 −
p∑
j=1
xijβj
)2
+ λ
p∑
j=1
β2j
 (2.19)
The term λ
∑p
j=1 β
2
j is called the L2 penalty.
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Elastic net
The elastic net is one attempt to combine the L1 and L2 penalties of Lasso and
ridge regression. If some variables are correlated, more variables than in Lasso
will tend to be included in the final suggested fit. Still, like Lasso, it reduces the
number of variables in the model[17].
(Naïve) elastic net is defined by:
βˆ = minβ
N∑
i=1
(
yi − β0 −
p∑
j=1
xijβj
)2
, s.t. (1− α)
p∑
j=1
|βj|+ α
p∑
j=1
β2j ≤ t,
(2.20)
where α is a constant defined by the restrictions laid upon the penalties defined
by α = λ2/(λ1 + λ2). λ1 is the Lasso penalty parameter and λ2 is the ridge
penalty parameter. Leaving one of them zero leads to the other regularisation
method:
• λ2 = 0⇒ α = 0⇒ Lasso
• λ1 = 0⇒ α = 1⇒ Ridge regression.
Comparison to (2.3) shows the similarity to Lasso and ridge regression.
The naïve elastic net performs poorly when it differs greatly from either Lasso
or ridge regression. To eliminate this disadvantage, a suggestion is to scale βˆ by
a factor[17].
2.2.7 Cross-validation
When fitting a model on a training set, we wish to minimise the difference between
the prediction and the actual observation, i.e. yi − yˆi. One way to do this would
be to minimise the mean squared error (MSE):
1
n
n∑
i=1
(yi − yˆi)2 = 1
n
n∑
i=1
e2i , ei = yi − yˆi
In a situation where p >> n, however, the MSE would be zero for several different
values of β.
Such a procedure would be less suitable for any other data. Adding a penalty,
such as Lasso (see Section 2.2.2), will restrict the model. However, we can just
choose λ = 0 in (2.4), and we are left with exactly the same problem as before.
Even if we did not have a possibly overfitted model, training the model on a
specific data set may make it a poor model for a general case. Having a separate
test set would be beneficial to test the model’s general usefulness. That way, we
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could set the model parameter λ to a specific positive value, leading to f(λ,xi),
try it out on a test set by estimating the MSE
MSE =
1
n
n∑
j=1
(f(λ,xj)− Yj)2, (2.21)
where (xj, Yj) are the observation pairs in the test set. Set λ to a new value,
make a new model, run this in the test set, find the MSE. Iterate this until the
λ that gives the minimum of MSE has been identified.
The aim of this is not to use the same data that we trained the model on
to test it. Unfortunately, the general solution is not yet obvious. The test set
may not be representative for a general case, in fact usually they are not. And
just optimising the model on the one data set, would make it suitable for the
test set, but not generally. The dream scenario would be to have infinitely many
different data sets to test the model on and find the one that fits most. With that
information, the predicted squared error (PSE) could be calculated. PSE is
the error of the model tested on future observations. Then we would have a
model that performs well on any data set.
Having infinitely many data sets is impossible. Instead, we can use the one
data set available to both train and test the model in several iterations, so called
cross-validation (CV).
The CV process
An illustration of the CV flow can be found in Figure 2.2. The general idea of
CV is to separate m observations from the data set, make a model based on the
remaining n − m and test it on the m observations outside the data set. The
left-out group of size m is called the test set, while the remaining group of size
n−m is called the training set. Repeat this such that all observations are used
once as the test set.
Saym = 1, which means there areK = n groups of size 1. This is called leave-
one-out cross-validation (LOOCV) . (Later, K-fold CV will be introduced.)
Say we have a penalised model that depends on a parameter λ:
f(λ,xi) = β(λ)
Txi, (2.22)
which is similar to the regression model presented in Section 2.2.1. CV can be
used to find the λ that, inserted in f , minimises the CV error,
CV (λ;X,y) =
1
n
n∑
i=1
(yi − f (−i)(λ,xi))2. (2.23)
f (−i) is the model trained on xj for j = 1, . . . , n except for i. Fix λ, leave out
observation i, train a model on the remaining data, and test on i. Do this for
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Figure 2.2: Flow of CV. First, the data set is split into groups, then a λ is
chosen. One group is marked as the test set, the other groups as the training set.
A model based on the training set is used to predict the values in the test set and
an error is recorded. Do this until all groups have been used as the test group and
find the average error for this λ. Fix a new λ and repeat. Finally, choose the λ
that gives the smallest error.
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every i = 1, . . . , n and sum up the error term and find the average error. Try a
new value for λ and repeat.
By calculating CV for several values of λ, we can choose the λ that gives
the lowest value of CV , and find the model f(λ(−i), X) based on data from all
observations.
An important property of CV (λ) is that
E(CV (λ)) ≈ PSE(λ), (2.24)
where PSE is the difference between the model and the unobservable real model.
In words, the expected shape of the curve of CV (λ) is approximately equal to
the PSE, see Figure 2.3. CV (λ) is easy to calculate, even though PSE(λ) is not.
By performing CV, we find a good estimate of how the predicted error behaves.
Figure 2.3: Example of how CV and PSE may behave, according to
(2.24). The expected shape of CV is approximately the shape of PSE.
K-fold cross-validation
Choosing K = n, LOOCV, can be time consuming for large n and if there are
many λk to optimise λ. Instead, it is common to choose e.g. K = 10, such that
for every iteration, we remove m ≈ n/K individuals instead of just one. Only K
iterations are needed to calculate CV (λ;X,y), instead of n. This will reduce the
run time, and lower the variance of the prediction errors. LOOCV will result in
higher variance because the fits are trained on n nearly equal data sets[11]. For
time measurements, see Section 3.1, especially Figure 3.1.
If the sub data set used as test data is very small, the risk of having a dispro-
portional number of censored events present is greater, i.e. a test data set with
nearly none events is a nonrepresentable test set. How the censorings affect the
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model depends on what kind of CV is performed, see the list of alternatives in
Section 2.2.8. This can cause the wide range of suggested signatures in K-fold
CV where K is large.
2.2.8 Cross-validation and the Cox model
So far, CV has been introduced in combination with the linear regression model.
Now, we will look at Cox regression. Recall (2.15), the Cox partial log likelihood
is defined by
l(β) =
∑
i:Ci=1
(βTxi − log
∑
j:Yj≥Yi
θj) =
∑
i:Ci=1
ϕi(β), (2.25)
where θj = exp(βTxj). With Lasso penalty, it is
lpen(β, λ) =
∑
i:Ci=1
ϕi(β) + λ
p∑
j=1
|βj| (2.26)
For more information, see Section 2.2.2. The regression model f is now replaced
with the partial likelihood l, with penalised likelihood lpen.
The purpose of using CV to find the best fitting Cox model, is to find the
optimal model parameter λ, as for linear regression. Usually, as in the case of
(2.22), the likelihood contribution of the i’th individual is independent of the
other individuals (when i 6= j). So, when cross-validating, it is easy to make the
expression f (−i) where observation i is excluded, see (2.23). But, because part two
of ϕi(β), i.e. log
∑
j:Yj≥Yi θj = log
∑
j:Yj≥Yi exp(β
Txj), depends on information
about other observations than itself (those in the still-at-risk group), we cannot
use CV directly as described earlier where each observation is removed.
Three variations of CV for the Cox model are described below. Every variation
maintains a quality of general CV, at the cost of others. Common for all CV
variations are that the λ that maximises the cross-validated likelihood (CVL) is
the λ that gives the best model.
1. Kuk[19] presented a type which is based on changing the status of one
observation i from non-censored to censored, which is done for each non-
censored observation. Changing the event indicator is the corresponding
action to removing observation i from the set as in ordinary CV. This
means that individual i affects the risk of all individuals still at risk until
the time of event i (which is no longer considered an event).
CVL =
∑
i:Ci=1
ϕi
(
βˆ(λ)(i)
)
, (2.27)
where βˆ(λ)(i) is estimated by maximising the penalised partial likelihood
(2.26) for a given parameter λ based on the data set where censor indicator i
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has been changed from non-censored to censored[11]. This method is similar
to ordinary CV for a general likelihood model. The fact that individual i
was alive up until ti is used, but not the fact that he/she dies.
2. Another option was presented by Verweij and Van Houwelingen[20]. This
takes into account that the components of the partial likelihoods affect each
other. The effect of observation i is defined as li(β) = l(β)− l−i(β) where
l−i(β) is the log-likelihood when observation i is left out. Linked to this,
the βˆ that maximises l−i(β) is denoted βˆ(−i). The CVL is defined by∑n
i=1 li(βˆ
(−i)), and considering the penalised likelihood:
CVL =
n∑
i=1
li
(
βˆ(λ)(−i)
)
, (2.28)
where βˆ(λ)(i) is estimated by maximising the penalised partial likelihood
(2.26) for a given parameter λ.
3. One version was presented in Hege L. Størvold’s master thesis[11]. This is
based on the idea of general CV. We ignore that the contribution of one
observation may affect the likelihood of another, so for every calculation of
the likelihood in the loops of the CV, observation i is removed entirely, as
if it did not exist at all.
CVL =
∑
i:Ci=1
ϕi
(
βˆ(λ)(i)
)
(2.29)
This is a hybrid of the previous CV variations; the formula is similar to
Kuk’s proposal[19], but the βˆ(λ)(i) is calculated as in Verweij and Van
Houwelingen’s proposal[20] where βˆ(λ)(i) is estimated by maximising the
penalised partial likelihood (2.26) for a given parameter λ based on the
data set where observation i is left out. Maximisation of the penalised
log-likelihood is a common way to find the best λ[21].
In summary, CV for the Cox model may ignore that the observations may
affect the likelihood of each other (3), a censored observation may be treated as
non-censored up until event (1) or we can consider that the observations may
affect the likelihood of each other (2).
2.3 Computations in R
There are several R packages that perform the statistics described in Section
2.2. The package penalized[22] is used in the CRC paper[1] and is the package
mainly used in this study. In addition, the package glmnet has been tested to
some degree.
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2.3.1 penalized
The function optL1 from penalized is the one used by Sveen et al.[1]. It takes
input including a Survival object (time and event) and covariates (X matrix, gene
expression levels), and optionally an interval for the value of λ in (2.4) and K for
K-fold CV. A typical call looks like this:
opt <- optL1(Surv(time , event), penalized=genes , fold
=10)
The genes matrix consists of elements where each row represents an observation
and each column represents a gene, as in (2.1). The fold parameter, i.e. K,
decides how many groups the data set should be split into in the CV process.
Recall the step by step algorithm from Section 1.1. If fold is set to n, the number
of observations, it will result in LOOCV. In the CV the data set is split into n
groups of size 1.
Output
optL1 suggests a regression model and the coefficients for the covariates can be
found by:
coeffs <- coefficients(opt$fullfit)
These coefficients are the βis from Sections 2.2.2 and 2.2.5 and describes the
weights of the genes. Only the non-zero coeffcients are included in the final model,
and obviously then length(coeffs) will give the number of genes supposedly
relevant to the response.
Challenges with optL1
As mentioned in the documentation[22], it is not certain that optL1 always man-
ages to pick the λ that gives global minimum error:
The optL1 [...] functions use Brent’s algorithm for minimization
without derivatives [...]. There is a risk that these functions converge
to a local instead of a global optimum. This is especially the case
for optL1, as the cross-validated likelihood as a function of lambda1
quite often has local optima. It is recommended to use optL1 in
combination with profL1 to check whether optL1 has converged to
the right optimum.
We can take a look at the CVL path by applying the function profL1:
prof <- profL1(Surv(time , event), penalized=genes , step
=20, fold=opt$fold)
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Figure 2.4: CVL plot from profL1 function. The plot shows the CVL value
for increasing values of λ. This should be as close to zero as possible, i.e. the
maximum which can be found at λ ≈ 15. The red line marks optL1’s choice of λ.
The function takes nearly the same parameters as optL1, but to be able to see
the previous object opt’s path, the exact same folding must be used. Even if we
call the function with the same number of folds, the grouping varies from time
to time, so to avoid this we need to specify fold=opt$fold.
profL1 shows the steps of the optimisation. A greater value of the parameter
step will show more detail. It is interesting to look at the plots of profL1 called
by:
plot(prof$lambda , prof$cvl)
plotpath(prof$fullfit)
These calls give plots shown in Figures 2.4 and 2.5, respectively.
The maximum of the CVL plot in Figure 2.4 gives the optimal λ, which is
about 15 in this particular case. By tracing the λ over to the plot to the right,
taking notice of how many lines present at lambda1=15, we can see that many,
more than ten, coefficients are non-zero.
The plot in Figure 2.5 is a nice way to illustrate the effect of the model
parameter λ. As λ decreases the number of non-zero coefficients increases. In
the extreme case of λ = 0, there would be no constrain on the penalised ex-
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Figure 2.5: Path plot from profL1 function. The λ that gave the maximum
value from the plot in Figure 2.4, about λ = 15, represents a large gene signature.
The red line marks optL1’s choice of λ which results in a gene signature of size
9.
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pression βˆ = argminβ 12
∑N
i=1
(
yi − β0 −
∑p
j=1 xijβj
)2
+ λ
∑p
j=1 |βj| (see Section
2.2.2) making it unpenalised. By making λ greater, it affects the model more and
more and eventually the model would have no non-zero coefficients.
Investigation of the optimisation path can detect errors where a local min-
imum error (the value marked with the red line in Figure 2.4) has given the
suggested λ instead of the λ with the global minimum error. We may correct the
call to optL1 by
# Find the lambda that gives global minimum error
prlambda <- prof$lambda[match(max(prof$cvl), prof$cvl)]
opt <- optL1(Surv(time , event), penalized=genes , fold
=10, minlambda1 =(prlambda -1), maxlambda1 =( prlambda
+1))
This will force the λ to stay in a close interval around the optimal λ found by
profL1.
2.3.2 glmnet
glmnet uses an algorithm called coordinate descent to find the λ that minimises
the error. This algorithm is faster than penalized, which uses the full gradient
method in combination with Newton Raphson.
The application of glmnet is similar to penalized[23].
cv <- cv.glmnet(genes , Surv(time , event), nfolds =10,
alpha=1, family="cox") # Cross -validation
fit <- glmnet(genes , Surv(time , event), alpha=1, family
="cox") # Model
The CV finds an optimal λ:
> print(cv$lambda.min)
[1] 0.2221717
This value of λ can be traced to the corresponding value on the x-axis in Figure
2.6, marked by the vertical left line. As can be seen in the plot (at the top), the
number of non-zero coefficients in the model is two. This is confirmed by:
> coeffs_vec <- as.matrix(coef(fit , s = cv$lambda.min))
> index <- which(coeffs_vec != 0)
> coeffs <- coeffs_vec[index]
> print(index)
[1] 112 199
> print(coeffs)
[1] -0.1114382 -0.2391665
The genes are represented in the 112th and 199th columns in the gene expression
matrix genes and the coefficient estimates are β112 ≈ −0.11 and β199 ≈ −0.24.
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Figure 2.6: CV plot of the glmnet model. The left vertical line marks
the minimum point with x-value corresponding to the optimal λ. The right line
marks the model which is one standard deviation away from model that gives the
minimum error. The number of non-zero coefficients in the model is shown at
the top of the plot.
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2.3.3 Differences
Both glmnet and penalized base their calculations on generalised linear models
(GLM) and they both maximise the penalised log-likelihood described in Section
2.2.8 where λ is the penalty parameter corresponding to lambda in R.
The main difference described in the documentation[22][24] between the two
methods is how they estimate the fits, i.e. βˆ, given λ. penalized applies the full
gradient algorithm and Newton Raphson when the optimal value is approached.
glmnet applies coordinate descent which is much faster. Also, the CV is different,
but it was difficult to find documentation of this without thoroughly reading the
source code.
The computations in this study show that the two R packages do not always
give the same results, see Section 4.5.3, but it is difficult to understand why from
the documentation. Even though λ is defined as the penalty parameter in the
penalised log-likelihood in both packages, the values are very different from each
other as the examples above have shown. This is also discussed in Section 4.5.3.
2.4 Recent work
Xu et al.[25] write that
A sparse algorithm cannot be stable and vice versa. [. . . ] In partic-
ular, our general result implies that L1-regularised regression (Lasso)
cannot be stable, while L2-regularised regression [Ridge] is known to
have strong stability properties and is therefore not sparse.[25]
Here, stability describes how the result of an algorithm varies from one data
set to another data set which is nearly identical to the first. The instability
discussed in this thesis instead describes how the fold in CV affects the result of
Lasso, so called model-selection variability. This topic has been discussed[26][27].
Roberts[26] proposes to apply a method called percentile-Lasso to overcome this
instability, which he reasons with an illustration similar to Figure 4.17, which is
more thouroughly discussed in Section 4.5.1.
Percentile-Lasso
This section is based entirely on [26]. CV’s choice of λ seems to be somewhat small
compared to the number of real relevant covariates included in the prediction
model. A larger λ would give fewer non-zero coefficients, and mostly it would
be the coefficients of the irrelevant genes that would be reduced to zero first.
Percentile-Lasso can be a useful guide in the choice of λ. The algorithm is as
follows:
1. Perform K-fold CV and Lasso. Take note of the choice of λ, denoted λˆ1.
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2. Repeat step 1 N times s.t. a vector Λ(N) = (λˆ1, λˆ2, . . . , λˆN) is obtained.
3. Find the θth largest value of Λ(N), denoted λˆ(θ).
4. Set λ = λˆ(θ).
An algorithm of how to choose θ is discussed in Roberts’ paper, but a typical
choice would be θ ≥ 0.75 ·N , i.e. the 75-percentile or greater, reflecting how the
normal Lasso tends to choose too small λs. A value as great as θ = 0.95 · N is
proposed.
Roberts discusses how the percentile-Lasso improves the normal Lasso by
how it decreases the model-selection error and the variance of the size of the
predictive models. It is also easy to apply to normal Lasso. A downside is that the
percentile-Lasso is more time-consuming than the normal Lasso in combination
with CV. However, that should not be an issue as modern computers have high
speed and compared to the importance of a good prediction result, time is nearly
irrelevant.
Chapter 3
Methods
There may be several reasons for the instability of the results from Lasso in
the paper about CRC[1], mentioned in the introduction. Some initial thoughts
were discussed in Section 1.1. In this chapter there is first a description of some
challenges when using K-fold CV and R, then follows how simulation have been
used to study properties of Lasso and K-fold CV, how properties of the data set
affects the prediction result, and finally some graphical displays used later are
presented.
3.1 Causes
3.1.1 K-fold cross-validation
The most worrying property of the results in [1], is that they are not unique. The
same data set is sent into the R function optL1 every time, but the coefficients in
the result vary. Some variation is expected because the grouping in the CV pro-
cess is random. However, the level of variation seen in [1] is worrying, motivating
a closer look at the CV process, including simulations.
In [1], K-fold CV is repeated, with K = 10, 1000 times. A boundary of fifty
is chosen in Sveen’s paper[1] and the eight signatures that appear more times
than that are kept. Because there are validation series available, they are able
to test the signatures on these. First, one of the validation series is used to pick
out the signature that gives the smallest error in that data set. Then, the other
validation series is used to verify that this signature is sensible.
Now, such validation series may be absent and we would like to draw a con-
clusion based on our original data set. The purpose of the validation series would
then be, exactly that, to validate that the signatures behave satisfactory on in-
dependent data.
Therefore, it is interesting to investigate how simulated data sets with prede-
cided relevant covariates behave when run through optL1 with K-fold CV. Will
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LOO 10-fold 4-fold
n = 100 38.7 sec 4.8 sec 2.4 sec
n = 300 4.0 min 8.8 sec 3.9 sec
n = 1000 3 hrs 23 mins 29.2 secs 2 min 25.2 sec 60.5 sec
Figure 3.1: Average time spent by running LOOCV, 10-fold CV and 4-fold
CV once on a simulated data set with information about 1000 genes.
there be instability in these cases as well? Should the unstable behaviour be
expected? These questions are answered in Section 4.1 where knowledge of espe-
cially K-fold CV, as described in Section 2.2.7, and simulations as described in
this chapter are applied.
One of the reasons for choosing something other than LOOCV is to save
time. But how much time can actually be saved? Is the advantage of choosing
K ≤ n/2 so great that it is worth downgrading predictive accuracy? Running a
test in R, using optL1, with the same input every time (simulated survival data
with 1000 genes from n individuals and their survival times), the elapsed time
was measured, see Figure 3.1.1
It is not until there are more than 300 observations that LOOCV takes so much
time that it may be sensible to choose K-fold CV (K ≤ n/2) and run it several
times instead (to see which result singles out). The time difference between 10-
fold and 4-fold CV is considerable however, so as long as the properties of 4-fold
CV are as good as those of 10-fold CV, 4-fold CV is preferable when considering
time. However, the predictive accuracy is more important than the time gain of
choosing K-fold CV in favour of LOOCV.
3.1.2 Programming parameters
As discussed in Section 2.3, it is possible to put λ to be in a specific interval when
calling optL1, forcing it to stay in it. This may affect the prediction result. Also,
does optL1 actually pick out the correct genes?
The resulting models from the optL1 function should preferentially not vary
as much as they do. Using a different R package may be the solution. One of the
alternatives is glmnet. Still, the CV process comes first and then regularisation,
so the framework is the same. How does glmnet behave compared to optL1?
Does one function predict better than the other?
These questions are answered in Section 4.5. The computations are based on
simulations described in this chapter.
1The test was run on a computer with an Intel(R) Core(TM) i7 CPU (870 @ 2.93GHz, 3066
Mhz, 4 Core(s), 8 Logical Processor(s)) processor and 8 GB RAM.
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3.2 Simulations
In order to investigate the possible causes of instability listed in Section 3.1,
survival data sets were simulated. Mainly, two issues are interesting to investigate:
1. The variability of the results using K-fold CV on given data sets.
2. The variation of the Lasso results for different data sets generated by the
same probability model.
When simulating data, the recipe by Nygård et al.[28] was followed. They
were inspired by Datta et al.[29]. Simulated data sets enabled controlling data
set properties. Knowledge of which genes that actually are relevant beforehand
made it easier to say how successful the Lasso and CV were.
3.2.1 Data structure
Covariate matrix X
X is the matrix with observed gene expression levels. Every row represents one
observation (individual, patient) and every column represents one gene. The
numbers may for instance be a measure of how much a gene is expressed in each
observation, as introduced in Section 2.1.1. A typical number of observations is
n = 100, and the number of genes was set to p = 1000, making X a 100× 1000
matrix, in accordance with Nygård et al.[28].
The elements of X is drawn from a multivariate normal distribution with
zero mean vector. By varying some parameters, the relations between genes and
survival can be altered. The covariance matrix is made block by block, 100 genes
every time. The elements in the covariance matrices are defined as σ2i on the
diagonal, and ρσ2i off the diagonal for i = 1, 2, . . . , 10. i is the block index. ρ may
vary between 0, 0.3, 0.6 and 0.9, ranging from weaker to stronger gene covariance,
respectively. ρ = 0 would be no correlation at all (the columns in the covariance
matrix are independent of each other), while ρ = 1 would be complete correlation
(the columns are identical). Alternatives for σ are as follows:
1. All the gene expressions have the same variance. σ2i = 1 for i = 1, 2, . . . , 10.
2. The first 200 gene expressions have greater variance. σ21 = σ22 = 2, σ2i = 1
for i = 3, 4, . . . , 10.
3. The first 200 gene expressions have less variance. σ21 = σ22 = 0.5, σ2i = 1
for i = 3, 4, . . . , 10.
These three alternatives cover a range of variations. The control of the gene
effect strength within each block of 100 genes is described in the next section,
whereas the overall effect of the blocks can be controlled by σ2i : equal for all
blocks, stronger or weaker in the two first blocks.
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Gene effects
When simulating survival times, the relation between gene expressions and sur-
vival is affected by
η = q
100∑
j=1
Xjβj − q
200∑
j=101
Xjβj = q
100∑
j=1
βj(Xj −Xj+100), (3.1)
where Xj is the jth column (gene) of X and βj = βj+100 = exp(−a(j − 1)) for
j = 1, . . . , 100. Only the 200 first genes are thus related to survival. These genes
are made up of two blocks and they will cover two peaks of strong gene effects.
The constant a is given by exp(−a(k − 1)) = 0.5, and so
a =
ln 0.5
1− k =
1
(1− k) ln 2 (3.2)
k is set to 10, 50 or 100, describing that the k first genes in block 1 and 2 have
an effect of more than 0.5.2 The slope of β is illustrated in Figure 3.2.
Figure 3.2: Gene effect slope. The shape of the β slope. The left plot shows
the situation where k is small, whereas to the right, the k has been increased. βk
is always 0.5, and β1 is 1.
E.g. for k = 10, the first 100 elements of β will look like this β1:100 = [1,
0.92, 0.85, . . . , 0.5, . . . , 0.00]T where 0.5 is the 10th element and the last elements
are so small that correcting to two decimal places, they are zero. Now take a
closer look at the right hand side of (3.1). Because βj is larger for j small, the
differences between the first genes in the two blocks affect the prediction outcome
more than the next genes. This way, η describes the effect of the gene expression
levels in the covariate matrix X, and the first genes in the two first blocks are
2Note that this k is different from the K in K-fold CV. It may be a bit confusing that these
two are similarly named, but care will be taken to always place the term in the correct context
to ease the understanding. This way, the notation can stay true to the common or original
form.
3.2. SIMULATIONS 33
expected to appear more frequently when searching for the relevant genes, if the
method works properly.
When a is found and used to find β, we may find q, which is needed to find
η. The q we decide to use, is the one that makes the variance of η to be 1. Thus
Var(η) =
1
n
n∑
i=1
(ηi − µ)2 = 1, µ = 1
n
n∑
i=1
ηi, (3.3)
for some large n, say 100. This is used to find the q that solves (3.3).
q =
√
n∑n
i=1(φi − 1nφ)2
(3.4)
The values of φi are easily implemented in R, and so it is no problem to find
q. With X from the previous section and β and q above, the value of η may be
found, leading us onwards.
Survival times
Following Nygård et al.[28], survival times from a Weibull distribution with haz-
ard rate h(x) = 5x4 exp(η) are drawn. η comes from the estimation of gene
effects.
To draw Weibull distributed numbers, a scale λ and a shape k to fit to the
standard h(x; k, λ) = k
λ
(x
λ
)k−1 are required. In this case k = 5 and λ is found by
5
λ
(x
λ
)4
= 5x4 exp(η)
λ = exp(−η/5)
Censoring times
If observation i ended in death by the illness in interest, the indicator is set to 1:
δi = 1, otherwise δi = 0. To distribute censoring indicators, censoring times were
simulated.
The simulation of censoring times differs from [28]. Uniformly distributed
numbers between 0 and 2 are generated, as this is approximately the interval of
the survival times. The numbers are compared to the survival times. Say tcens
are the uniformly distributed numbers and tsurv are the survival times drawn
previously. Then for every pair of (tsurv, tcens)i for i = 1, . . . , 100:
• If tsurv < tcens: Keep tsurv as the survival time and put δ = 0 (noncensored),
• else, that is tsurv ≥ tcens: Replace the survival time with tcens and put δ = 1
(censored).
With this choice, approximately 50% of the observations are censored.
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3.2.2 Simulation parameters
There are several parameters in the algorithm described above that can alter the
behaviour of the data set. In summary:
• k = 10, 50, 100. The first genes in block 1 and 2 have the greatest
effect. Increasing k, i.e. slowing down the speed of gene effect decrease,
is expected to lead to greater signature sizes because the gene effects will
be more spread out. With a small k, the non-zero coefficients should be
grouped in the start of the two first blocks.
• ρ = 0, 0.3, 0.6, 0.9. Correlation between the genes. There are
several interesting aspects to look upon, e.g. if strong correlation between
genes result in small gene signatures, as expected. (For strongly correlated
groups that show relevance, Lasso includes only one variable and leaves the
rest[17].) That is, with ρ decreasing, greater signature sizes are expected.
• Three alternatives for variance: The genes in all ten gene blocks have
the same variance; the genes of the first two blocks differ from the rest
(greater or lower variance). For now, all genes are set to have the same
variance, 1.
• Number of observations n. A greater number of observations is expected
to lead to more accurate results: more of the (predecided) most relevant
genes will be picked out as relevant and there will be less false positives.
More observations tend to have the effect of better prediction, but it is not
guaranteed. If a new observation is an outlier, it may have a negative effect
on the prediction result.
The results of investigating the issues raised above are described in Section 4.3.
3.3 Displaying the results
Biostatistics with a large number of covariates have a tendency to bring on huge
amounts of information. In order to avoid getting lost in the jungle of information,
well-designed visualisation is important. A description of the diagrams that will
be used when the results are presented follows.
3.3.1 Signature size bar diagram
Visualising the resulting signature sizes from many runs on one specific data set
can easily be done with a bar diagram, as in Figure 1.2. Another example is
based on the data below and is shown to the right in Figure 3.3.
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Figure 3.3: Example of signature size heat map and bar diagram. The
bar diagram to the right shows one data set run 19 times, with 10-fold CV. The
sizes of the resulting 19 signatures are represented in the bars. E.g. there were
four signatures of size zero, no genes with non-zero coefficients. One row in the
heat map to the left shows the same information as the bar diagram; the darker
the colour, the higher bar. The heat map in total shows five data sets that has
been run 19 times each.
Size 0 1 2 3 4 5 6 7 8 9
Frequency 4 2 4 0 0 0 1 2 3 3
The signature sizes are represented along the x-axis and the height of the column
represents how many times the result signature is of that size.
3.3.2 Signature size heat map
Many runs on several different data sets and comparing the results with each
other can become messy and difficult to keep track of. Instead of several bar
diagrams, a heat map is used, as in Figure 3.3.
Every row in the heat map represents a number of runs with one specific data
set, like our previous bar diagram. The colours represent the bar height in the
bar diagram in Figure 3.3. Darker nuance symbolises a higher bar. The matrix
behind the heat map is as follows:
0 1 2 3 4 5 6 7 8 9
[1,] 4 2 4 0 0 0 1 2 3 3
[2,] 2 3 1 0 3 4 1 3 4 0
[3,] 0 0 1 1 0 4 2 2 3 0
[4,] 3 3 1 1 2 2 4 1 0 1
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[5,] 3 0 1 4 4 2 0 3 4 3
3.3.3 Gene index heat map
Sometimes it is interesting to look at which genes are picked out in the resulting
gene signature. A heat map may be used in this case as well, but with every
column representing a gene instead of signature size. A row will be a gene signa-
ture consisting of the indicated genes in that row, see heat map in Figure 3.4. A
coloured element in the heat map means that the gene has a non-zero coefficient
in the Lasso model.
3.3.4 Gene index density plot
Also, we may wish to look at the coefficient sizes. A density graph can be added
to visualise the sum of the coefficients for that gene (column). See density plot
in Figure 3.4.
Both the density plot and heat map in Figure 3.4 are based on this matrix:
[,1] [,2] [,3] [,4] [,5] [,6] [,7][,8] [,9] [,10]
[1,] 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 0.00 0.00
[2,] 0.12 0.00 0.12 0.12 0.12 0.12 0.12 0 0.12 0.12
[3,] 0.12 0.00 0.12 0.12 0.12 0.12 0.12 0 0.12 0.12
[4,] 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0 0.00 0.00
[5,] 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 0.00 0.00
[6,] 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 0.00 0.00
[7,] 0.14 0.00 0.14 0.14 0.14 0.14 0.00 0 0.14 0.14
[8,] 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0 0.00 0.00
[9,] 0.00 0.00 0.00 0.00 1.00 0.00 0.00 0 0.00 0.00
[10,] 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 0.00 0.00
[11,] 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0 0.00 0.00
[12,] 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0 0.00 0.00
[13,] 0.17 0.00 0.17 0.17 0.17 0.17 0.00 0 0.00 0.17
[14,] 0.00 0.00 0.00 0.00 1.00 0.00 0.00 0 0.00 0.00
[15,] 0.12 0.00 0.12 0.12 0.12 0.12 0.12 0 0.12 0.12
[16,] 0.14 0.00 0.14 0.14 0.14 0.14 0.00 0 0.14 0.14
[17,] 0.11 0.11 0.11 0.11 0.11 0.11 0.11 0 0.11 0.11
[18,] 0.11 0.11 0.11 0.11 0.11 0.11 0.11 0 0.11 0.11
[19,] 0.11 0.11 0.11 0.11 0.11 0.11 0.11 0 0.11 0.11
Note that this matrix also represent the bar diagram and row 1 in the heat
map in Figure 3.3. (The number of non-zero elements in every row is equal the
signature sizes.)
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Figure 3.4: Example of gene index heat map and coefficient density
plot. Upper: Every row in the heat map represents a gene signature. E.g. the
the signature on the row marked 19 contains nine genes with non-zero coefficients,
which is all genes except gene 8. Gene 8 is not present in any of the signatures.
The size of the coefficients are ignored in the heat map. Lower: The density plot
shows the sum of the coefficients for every gene. The x-axes in the heat map and
in the density plot correspond. Note that gene 8 sums to zero, but gene 5, which
is present in nearly all signatures, has the highest sum.
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The fact that all non-zero elements in each row are equal and sum up to one
is not usually the case. The data set here was generated for illustrative purposes
and should not be considered typical in real scenarios.
Chapter 4
Simulation Results
Data was simulated by following the recipe described in Section 3.2. The data
was then run through the R function optL1, which performs Lasso and CV and
was used in the CRC paper[1]. (For motivation and description see Section 1.1.)
Investigation of how Lasso behaves is interesting, as indicated by the CRC
example in Section 1.1. Generally it is interesting to see how Lasso behaves on
one data set, both with fixed fold parameter in K-fold CV set and also how the
result varies between different folds. Another interesting aspect is whether some
data sets give less varying results than others, e.g. is the instability of the data
set of the CRC paper[1] an atypical result? And, does more observations lead to
more consistent results?
Unless specifically stated, the parameters are set to (i) k = 10, the first gene
with effect 1, the 10th with effect 0.5, then further decreasing; the k first genes in
each block have the largest effect, (ii) ρ = 0, no correlation, (iii) n = 100, number
of observations, and (iv) p = 1000, total number of genes.
4.1 The importance of the fold parameter
4.1.1 Variation within K-fold CV
Figure 4.1 shows an example with ten repetitions of Lasso and CV using optL1.
Even though it is the same data set every time, the result is varying. Because
the result is so variable, it may be nonsensible to draw a conclusion based on just
one or even ten runs. However, note that the smallest signature is of size two,
and that those two genes are present in all signatures. CV decides the value of λ,
so it only decides how many genes that are included. Thus all smaller signatures
will be contained in the larger ones, i.e. the gene of a 1-size signature is also
contained in all larger signatures, both genes in a 2-size signature are contained
in the larger signatures and so on.
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Figure 4.1: One dataset, 10-fold CV. The heat map (top) shows the result
of 10-fold CV on the same data set. Note that smaller signatures are contained in
the larger ones. The bar plot (bottom) shows the signatures summed up as sizes.
The number of genes in each row in the heat map is the ’size’ in the bar plot.
Note that the sum of the bar heights is the same as the number of rows in the
heat map (10) and shows the same information as Figure 1.2 in the introduction.
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Figure 4.2: One dataset, LOO and 10-fold CV. The heat map shows the
result of LOOCV and 10-fold CV on the same data set. LOOCV was run only
once because it results in a unique signature.
4.1.2 Leave-one-out or K-fold cross-validation
The pros and cons of K-fold CV were indicated earlier. It would appear that
LOOCV is the better alternative for uniqueness. It finds the best λ for the given
data set, and there is no randomness to it. K-fold CV on the other hand may
give a different result every time because the grouping into training and test sets
is different every time. A comparison of LOOCV and 10-fold CV can be seen in
Figure 4.2.
Even though LOOCV may be the best alternative by providing a unique
answer, it may not be the best alternative for the general case. First, K-fold
CV may actually be better if the model should be used for predictive measures
because it gives a hierarchy of signatures as utilised in [1]. Moreover, a paper by
Markatou et al.[30] states that K=4 is the best option, making the model stronger
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for the general case. The main argument against choosing LOOCV is that every
training set is nearly equal, because only one observation is excluded every time,
and therefore strongly depend on each other. This does not train models well for
a general scenario, but instead makes it very suitable for the specific data set.
With K ≤ n/2 the differences between the training sets are greater, so the model
will be better suited for application on other data.
4.1.3 Variation between K-folds
How do different K-fold CV behave on the same data set? LOO, 25-fold, 20-fold,
10-fold, 5-fold, 4-fold and 3-fold CV were applied to the same data set, see Figure
4.3. It seems that 3-fold CV gives the largest signatures, i.e., highest λ. Is this
always the case? For visualisation of more data sets, see Figures A.12 and A.13.
A closer look at each pair of K-folds can be found in Figures A.1, A.2 and A.3.
A smaller K in K-fold seems to result in larger signatures, but an exception
can be seen in Figure A.13. Here, 10-fold CV seems to pick out fewer genes than
both 25-fold and 20-fold. Otherwise, the claim seems sensible.
Investigation of this behaviour on may data sets, e.g. 100, is preferable. In
the calculations behind Figure 4.3, the average signature size within each fold
was registered. The process was repeated for 100 data sets, even though just one
data set is presented here, in Figure 4.3, and two can be found in the appendix.
The average of all averages were calculated and the result was:
LOO 25-fold 20-fold 10-fold 5-fold 4-fold 3-fold
Average sig.size 10.0 10.8 11.1 12.2 14.8 15.9 18.1
The average signature size of all data sets are placed in Section A.1.
The claim that more folds, i.e. larger K, give more sparse signatures holds,
and, as previously mentioned, 4-fold CV has been suggested as the ideal fold[30]
when predicting a general case. Will smaller Ks give more stable results? This
question is not answered in this thesis, but would be interesting to look upon.
4.1.4 Summary
In this section, we have observed that:
• There are variations in the result from repetition to repetition when keeping
the same data set and repeatedly running K-fold CV and Lasso. LOOCV
gives a unique result, whereas K-fold for K ≤ n/2 gives varying results.
• More folds, i.e. larger K, give more sparse prognostic signatures.
• All smaller signatures are contained in the larger signatures.
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Figure 4.3: One dataset, different folds. The heat map shows the result of
Lasso and CV on the same data set with n = 100 observations. The columns are
the genes ranging from index 1 to the left to 1000 on the right. Each K-fold CV
(and Lasso) was performed 10 times, which resulted in 10 rows for each K-fold.
LOOCV was run only once as it gives a unique gene signature. Note how the
gene signature (genes with non-zero coefficient) goes less sparse as K in K-fold
decreases from LOO to 3.
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• These results are seen on simulated data with controlled behaviour, and are
thus not a result of some specific attributes of Sveen et al.’s data[1].
4.2 The effect of new data sets
The motivation for using regularisation methods are that we have many more
genes than observations, p >> n. Investigation of a rare condition, lack of
volunteers, or lack of appropriate biological material from tumour samples can
cause the observation set to be small. A typical size is about 100, as in the
CRC data set[1] where n = 95. Therefore, n = 100 is the default number of
observations in the simulated data sets.
4.2.1 n=100
Figure 4.4 shows the signatures when n = 100, where Lasso was run repeatedly
on new data sets. There is generally much noise, i.e. false positives, but peaks
can still be seen in the areas with real gene effects, roughly 1-20 and 101-120;
Lasso chooses the correct genes more often than irrelevant ones, but not as often
as would be preferable.
4.2.2 n=300
Tripling of n seems to improve the detection of the real gene effects, see Figure
4.5. The increment of the number of observations has led to a stronger differ-
ence between the first genes and the last genes in each of the two first blocks.
With more observations, the genes with estimated effects are grouped around the
expected areas, roughly 1-20 and 101-120.
In a case where the number of observations can be increased, more than 100
should preferentially be chosen. The pay off of having a greater observation set
is marked.
A function of n that describes the relation between the number of observations
and false positives would be useful. Whether a more formal approach to such a
function would be successful is unknown, but is discussed in Section 6.4.
Figure 4.6 displays the same information as in Figure 4.1, repeated runs with
10-fold CV on the same data set, but the data set consist of 300 observations
instead of 100. The two figures mentioned are based on just one data set each,
so take care when drawing conclusions. However, increasing the number of ob-
servations seems to make the optL1 results within the same data set markedly
more stable.
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Figure 4.4: 100 observations, LOOCV. The data sets have simulation pa-
rameters ρ = 0 and k = 10. The left plots show all 1000 genes whereas the
right plots are zoomed in on the first 200. There are many non-zero coefficients
outside the expected areas 1-10 and 101-110, but especially at 101-110, there are
more occurrences. Larger versions of these images can be found in Figures A.4
and A.5.
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Figure 4.5: 300 observations, LOOCV. Left: All 1000 genes. Right: The
first 200 genes. The effect of making the first genes more relevant to response is
markedly more obvious in this result compared to when n = 100, see Figure 4.4.
Larger versions of these images can be found in Figures A.6 and A.7.
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Figure 4.6: One dataset, 10-fold CV, n=300. The heat map shows the
result of 10-fold CV on the same data set.
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4.2.3 n=500
To further illustrate that increasing the observation set will lead to more precise
results, see Figure 4.7 where n = 500. The peaks are sharper, so the real relevant
genes have larger coefficients and appear in the predictive models more often.
Again, having more observations available is preferable for precision.
Of course, we cannot know for sure whether more observations will always
lead to more precise results as the search for an association between response
and covariates can lead to the finding of a pattern that is not really there.
4.2.4 Summary
More observations will lead to less varying behaviour of K-fold CV and Lasso in
general. The improvement by moving from 100 to 300 is large, and we may ask
if data sets of 100 observations are sufficient for drawing conclusions when p is
large.
Also, more observations seem to make Lasso choose larger signatures, compare
Figures 4.1 and 4.6, which is expected as the true relevant genes are more easily
found with the higher test power obtained when n is large.
4.3 The effect of simulation parameters
4.3.1 Variations in correlation
By varying ρ, we vary the correlation between the genes, see Section 3.2. ρ = 1
means complete correlation, and ρ = 0 means no correlation at all. When a group
of variables has strong correlation, the Lasso will tend to pick one of the variables
and leave out the rest. So decreasing the correlation ρ was expected to lead to
greater signatures, i.e. more genes with non-zero coefficients.
Figure 4.8 shows how the coloured boxes have a tendency to move to the right
as ρ decreases, i.e. the signatures are larger when the correlation decreases.
However, signature sizes drop when there is no correlation, ρ = 0. A display
of the signature sizes when the correlation moves from 0.3 to 0 shows a gradual
decrease, see Figure 4.9. A comparison of a run with the number of observations
equal 100 and another with n = 300, both with zero correlation, showed that the
signatures were greater when n = 300. The drop in signature size at ρ = 0 is most
likely due to the genes having too little power by themselves. With correlation
“they draw” effect from the correlated genes, which are then left out.
In Figure 4.10, optL1 was run once on every dataset, and the heat map
visualises how the non-zero coefficients are distributed related to gene index.
The bottom part consists of data sets generated with strong correlation, and the
top part with weak correlation. The correlation seems to affect which genes are
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Figure 4.7: 500 observations, LOOCV. Left: All 1000 genes. Right: The
first 200 genes. The effect of making the first genes more relevant to response is
more obvious in this result compared to both n = 100 and n = 300, see Figures
4.4 and 4.5. Larger versions of these images can be found in Figures A.8 and
A.9.
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Figure 4.8: Variations in correlation. These heat maps show the signature
sizes. Each row symbolises one dataset with N runs of optL1 (Lasso and K-fold
CV); Top: 10-fold CV; Bottom: LOOCV. For 10-fold CV, the function was run
N=100 times, i.e. the sum of each row is 100. The darker colours symbolises
greater values. LOOCV was run only once per dataset as it gives a unique answer.
Note: There are 300 observations in these data sets to more clearly see the effect.
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Figure 4.9: Weak correlation, n = 300. The signature sizes increased from
ρ = 0.9 to ρ = 0.3, but suddenly dropped at ρ = 0. The behaviour from ρ = 0.3 to
ρ = 0 is displayed in more detail here. There is a gradual decrease in signature
sizes.
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Figure 4.10: Variations in correlation, gene indices. n=300. This heat
map show the genes with non-zero coefficients after running optL1 with LOOCV.
Each row is a new dataset and a new run with optL1.
picked out in the predictive model. Stronger correlation results in less non-zero
coefficients in the irrelevant area (indices > 200).
The increased signature sizes seen in Figure 4.8 are also seen here, as there
are more red elements as ρ decreases, with an exception where ρ = 0. This is
explained in the previous section.
4.3.2 Variations in how fast the gene effect decreases
In Figure 4.11 the correlation is kept constant at 0.31 and n = 300, but the
speed of the gene effect reduction, k, is varied. Obviously, with k increasing,
larger signatures are expected because the gene effects would be more spread
1The correlation was not set to the neutral zero because of the drop in signature size effect
which was shown in Section 4.3.1.
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out. However, the normalisation performed when converting β to η, described in
Section 3.2.1, makes this claim complicated. The heat maps do not confirm the
previous claim; the sizes seem to be similar for all ks. If anything, the results of
10-fold CV seem more stable with a larger k.
Figure 4.12 shows the indices of the genes with non-zero coefficients in each
signature. One row represents one dataset run through optL1 with LOOCV once,
resulting in one signature. It was expected that k = 10 would lead the genes
clustered roughly in the intervals 1-10 and 101-110, or close to them, k = 50 in
the intervals 1-50 and 101-150, and so on. For k = 10, this seems to be the case.
For the other values of k it is difficult to say whether they differ from each other.
4.3.3 Summary
It is already known that Lasso normally chooses only one variable with non-zero
coefficients out of a (strongly) correlated group, so the effect of correlated genes
was expected; strong correlation give smaller signatures.
The drop in signature size when there was no correlation was unexpected.
The effect of each gene is weak by itself. It needs a correlated gene to draw
strength from. This probably causes the drop in signature sizes when ρ = 0.
More observations strengthen the gene effects, so the sudden appearance of zero-
signatures when ρ = 0 is not as dramatic when n = 300 as when n = 100.
The normalised gene effects complicates the expectancy of how the gene effect
distribution affects the result. The signature sizes seemed alike for all values of
k.
4.4 Reduction of small coefficients to zero
One of the benefits of Lasso is that it reduces the number of covariates with
non-zero coefficients. Other regularisation methods such as ridge only shrinks
the coefficients towards zero. However, even though Lasso picks a covariate with
non-zero coefficient, the coefficient may be very small. It may be so small that
in effect it does not contribute to the prediction. When the focus is on mapping
the relevant genes, i.e. not finding the exact coefficients but just finding the
genes with non-zero coefficients, these genes with small coefficients may be of no
interest. In fact, it would be useful to rule them out and instead find the most
relevant genes.
To strengthen the effects of the truly relevant genes, optL1’s choice of λ was
decreased by a constant eps=10. This way, λ is forced to move to the right
of Figure 2.5 which leads to more covariates; those that already were in the
model will mostly have greater coefficients, and the new covariates will have
small coefficients.
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Figure 4.11: Speed of the gene effect reduction, sizes. The simulation
parameters were set to n = 300 and ρ = 0.3. The heat maps show that the
signature sizes stay approximately the same even though the speed of the gene
effect reduction decreases. The top image shows 10-fold CV, and the bottom
image shows LOOCV.
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Figure 4.12: Speed of the gene effect reduction, indices. n = 300 and
ρ = 0.3. LOOCV. This heat map shows the genes with non-zero coefficients after
running optL1. Each row is a new dataset and a new run with optL1.
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Then the coefficients smaller than a limit cutoff were reduced to zero, ex-
cluding these genes from the model. The new set of coefficients of all genes form
the basis of this calculation:
sensitivity =
True Positives
True Positives + False Negatives
=
TP
TP + FN
, (4.1)
specificity =
True Negatives
False Positives + True Negatives
=
TN
FP + TN
. (4.2)
TP is the number of real relevant genes which have a non-zero coefficient,
FN are the real relevant genes with coefficient zero, FP are the irrelevant genes
which have a non-zero coefficient and TN are the irrelevant genes with coeffi-
cient zero. The terms are summarised in Figure 4.13. Sensitivity is also called
Figure 4.13: ROC grid.
True Positive Rate (TPR), and specificity is 1−False Positive Rate (FPR). The
relation between these numbers are visualised in an ROC (Receiver Operating
Characteristic)[13] in Figure 4.14.
The ROC curve is based on simulated data with simulation parameters n =
300, ρ = 0.3, p = 1000 (genes) and k = 10. The relevant genes were therefore
defined to be the genes with indices 1-20 and 101-120. optL1 with 10-fold CV
was run on the data set, λ decreased by 10, which resulted in a prediction model.
To more easily see how well optL1 picks out the real relevant genes among the
first 100, the coefficients of the genes with indices greater than 100 were ignored.
The set of 100 coefficients formed the basis of the calculations described in
(4.1) and (4.2). The cutoff-limits were set to 0, 0.025, 0.05, 0.075, 0.1, 0.125, 0.15
and 0.175, forming a new predictive model every time. For every new model,
sensitivity and specificity were calculated. 10-fold CV and cutoffs were repeated
several times, and the average of sensitivities and specificities were calculated.
This again was applied on many data sets and the averages were calculated.
These values are presented in the ROC.
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Figure 4.14: ROC of cutoff effect when λ has been decreased by 10.
The x-axis describes (1-specificity) which is equivalent with FPR, and the y-axis
describes the sensitivity which is equivalent to TPR. If a model is well fitted, TPR
should be large and FPR small. The models are marked by circles in the plot with
cutoff-valued label. Markings above the diagonal line are well fit.
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The perfect model would have only the real relevant genes and no irrelevant
genes, i.e. perfectly classified, which would be represented by a point in the
ROC at (0,1). If genes were picked at random, the corresponding points would
be placed on the diagonal line y = x. I.e. that points above the diagonal line
represent a good prediction, and points below bad predictions, even worse than
random. The distance to the diagonal reflects the quality of the predictive model:
The point (0,1) is furthest away, positively, and is perfectly classified. A model
with all coefficients non-zero gives FN=0 and TN=0 which gives sensitivity 1 and
specificity 0. This would give the point (1,1). A model with only zero-coefficients
will result in the point (0,0).
The ROC shows that the models lie close to a random guess. Of course,
the size of the coefficients are not considered, which means that an irrelevant
gene with non-zero coefficient is weighted equally as a relevant gene with non-
zero coefficient. Hopefully, removing genes with very small coefficients from the
model (reducing the coefficient to zero) would lead to better predictive models,
but this does not seem to be the case.
Notice that even after reducing the number of genes in focus to 100, because
of the sparsity of Lasso, TN will always be large, which implies specificity ≈ 1,
i.e. the points will have x-coordinate close to 0, which is good. Also, it seems
that FN will be large compared to TP, so sensitivity and the y-coordinate will
be close to zero. Reflecting on this, it is not so strange that the points in Figure
4.14 lie close to (0,0).
4.5 Program systems
4.5.1 penalized
Checking for global minimum error
As discussed in Section 2.3, the function optL1 in the R package penalized is
imperfect. The search for the best λ can result in a λ that gives a local least
error. To avoid this, the function profL1 can be used to check the behaviour
of the likelihood and verify the chosen λ. Given a data set, this comparison is
interesting:
1. Run as normal with just optL1. Which genes have non-zero coefficients in
the proposed gene signature?
2. Check with profL1 and force the λ in optL1 to be the λ resulting in global
least error. Which genes are in the signature now?
These tests were run on a data set and are presented in heat maps in Figure 4.15.
Notice how some rows (2, 5) are blank after adjusting for global minimum
error. This is because optL1 originally chose a local λ, while profL1’s choice is a
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Figure 4.15: Checking for global minimum error. Heat maps correspond-
ing to the aspects discussed in Section 4.5.1. Both heat maps are based on the
same data set, but every row is a new run with optL1. Top: Run as normal.
Bottom: Replace λs that give local minimum error with global λ. For more
examples, see Figures A.14 and A.15.
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very large λ that includes no covariates in the predictive model. Some rows show
no change, whereas some show small change, e.g. rows 4 and 10.
When optL1 and profL1 disagree about the choice of λ, one function does
not necessarily choose a larger signature than the other. The difference in num-
ber of non-zero coefficients in such cases are sometimes in favour of optL1 and
sometimes in favour of profL1 even though from Figure 4.15 it may seem that
profL1 chooses smaller signatures because of the blank lines.
Does optL1 pick out the correct genes, and what is LOOCV’s sugges-
tion?
The behaviour of optL1 for varying λ is shown in Figure 4.16. The gene effects
are here set to constant such that genes with indices 1-20 and 101-120 are one,
and the rest zero. The genes with effect one are named ”correct” whereas the rest
are ”incorrect”. Note that each subfigure is based on just one data set.
From Section 4.2 we know that more observations lead to more correct results.
Figure 4.17 shows the corresponding plots to Figure 4.16, but the number of
observations has been increased to n = 300. Remember that there may be large
differences between data sets, because the predictive result depends on data set
properties as seen in Section 4.3, so be careful when comparing the plots.
The line that represents the correct genes is nearly constant, especially when
n is large, but the number of incorrect genes decreases as λ increases. LOOCV’s
choice of λ in Figure 4.16 is small if focusing on the relation correct vs. incorrect
genes. λ could have been increased just a little bit, and would have had the same
number of correct genes, but fewer incorrect genes. This may be unique for these
particular data sets, but LOOCV does tend to choose a small λ[26]. A suggestion
for solving this problem is discussed in Sections 2.4 and 6.2.
4.5.2 glmnet
How well does glmnet pick out the genes with strong effects compared
to penalized?
Data was simulated in the same way as for penalized, but was run through the
R package glmnet instead. k was set to 10, so the genes with indices 1-10 and
101-110 were expected to show up more often in the gene signatures. But, there
seemed to be more noise than for the results of optL1,shown in Figure 4.4. The
glmnet results are shown in the left hand side of Figure 4.18. A direct comparison
of the two R functions when n = 100 is not recommended. The data set is too
small, so any differences may be a result of randomness. However, by increasing
the observation size to n = 300, the expected shape shows up, see the right hand
side of Figure 4.18.
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Figure 4.16: Visualisation of how well optL1 picks out the correct genes
for varying λ. The simulation parameters are set to n = 100, ρ = 0.3 and k
constant s.t. genes 1-20 and 101-120 have effect of size one. Each subfigure is
based on one data set.
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Figure 4.17: Visualisation of how well optL1 picks out the correct genes
for varying λ, n = 300. Figure corresponding to Figure 4.16. The number of
observations has been increased to n = 300, the other simulation parameters as
before.
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Figure 4.18: Glmnet, LOOCV. The two plots to the left are based on data
with n = 100 observations. The plots to the right are based on data with n = 300
observations. For larger images, see Figures A.10 and A.11.
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4.5.3 Do glmnet and penalized agree?
Both glmnet and penalized use the same approach to find the best prognostic
gene signature: Lasso and CV. The results of LOOCV of both methods are shown
in Figure 4.19. The simulation parameters of the data sets in this computation
were set to: n = 300, k = 10, ρ = 0.3.
The black elements in the heat map represent a gene that both penalized
and glmnet gave a non-zero coefficient. These are frequent, but there are also
green and pink elements present. These represent genes that only glmnet or only
penalized gave non-zero coefficients, respectively.
The presence of many black elements are reassuring as it means that the two
methods mostly agree. The number of green elements seem to exceed the number
of pink elements, which indicate that penalized tend to pick more sparse models
than glmnet.
Also, CV chooses the best penalty parameter λ, but the underlying model
should be the same every time, which causes all smaller signatures to be contained
in the larger ones, as seen previously. One would think that the difference between
the two R packages is the CV process. However, LOOCV eliminates this factor
and some rows in Figure 4.19 contain both pink and green elements which mean
that penalized’s signature is not contained in glmnet’s, or the other way around.
There must be other differences than CV.
From the documentation[22][24] it seems that λ is identically defined in both
packages. Forcing the λ to be equal2 in either function results in different signa-
tures, and results in a heat map alike Figure 4.19.
4.5.4 Summary
The risk of choosing a λ from a non-global minimum point on the error curve
is considerable, as can be seen in Figure 4.15. To achieve a reliable result, this
must be taken into account and it should be made sure that the chosen λ gives
the global least error. Even though optL1 converges and settles, verification with
profL1 should be performed, unless we will risk ending up with a too sparse or
too large set of genes with non-zero coefficients.
Also, as shown by comparing penalized and glmnet, the result depends on
the R package applied. This may indicate that the final results from an analysis
preferentially should be checked.
2The values of λ are different in the two packages. glmnet uses values between 0 and 1,
whereas penalized uses values approximately between 15 an 40. Computations show that the
relation is 105 · λglmnet ≈ λpenalized.
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Figure 4.19: Comparison of glmnet and penalized. Each row represents
the signatures chosen by LOOCV with glmnet and penalized, based on the same
data set with 310 observations. The columns correspond to the genes, as described
in Figure 3.4, but only the genes with indices 1-200 are displayed here. All 1000
genes can be seen in Figure A.16. Black: Both penalized and glmnet have
given this gene a non-zero coefficient. Pink: Only penalized has given this
gene a non-zero coefficient. Green: Only glmnet.
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4.5.5 p-value and variance filter
In Sveen et al.’s paper[1], a filter was applied before running the data trough CV
and Lasso. To reduce the data set size, they ran univariate Cox proportional
hazards analyses on the gene expression data and obtained Wald p-values. Sveen
et al. also calculated the variance of all genes. The genes with variance less than
0.2 and p-value greater than 0.5 were left out in the continued investigation as
they were considered uninteresting and probably irrelevant.
The p-value filter is probably applicable on simulated data as well. The
variance of our simulated data is restricted by the parameter alt which is set
to one for all simulations. This choice results in a gene expression matrix where
every column has variance approximately equal one. The first genes have no
different variance from the other genes, so application of a variance filter would
be useless.
To see how filtering by eliminating genes with low p-values affects the simu-
lated data, two sets of images were produced, shown in Figure 4.20. There is no
great difference. The maximum points are similar, and there seems to be equally
much noise, i.e. false positives.
Even though the filter may have a positive effect on the simulated data as
well, it was not generally applied in the investigations in this thesis. This way
there are fewer factors that may affect the results.
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Figure 4.20: Filter on and off. These plots were generated after simulating
data with zero correlation, 300 observations and k = 10. Left: The p-value
and variance filter is switched on. Right: The filter is switched off. The plots
show the distribution of the 200 first genes in the fits resulting from optL1 in
penalized with 10-fold CV. The density plots show the sum of the coefficients
and the heat maps show which genes are included in each signature. Every row
represents one signature, generated from different data sets.

Chapter 5
Estimation of Accuracy
The varying results of optL1, with the same input data set, is caused by K-fold
CV. When there are as many groups as there are observations, i.e. LOOCV, the
result is identical from run to run.
The instability is worrying because it is difficult to propose a single prognostic
gene signature, which would be the easiest to interpret. But, the hierarchy of
signatures, where each smaller signature is contained in the bigger ones, provides
an opportunity to test several models. Sveen et al.[1] utilises this hierarchy and
the three available data sets to settle for one model. The first data set was the
training set which is the foundation of the model. The next set, test set 1, was
used to test the models suggested by step one and find the best model. The third
data set, test set 2, was the validation set. If LOOCV had been used, they would
not have had the range of models to test, and Sveen et al.[1] may have settled on
a different model.
5.1 The range of signatures
The varying result of K-fold CV where K ≤ n/2 can be used in our benefit.
A wide range of signatures where no signature appears more often than others
indicate that it is difficult to say which is the better prognostic signature. On the
other hand, a more narrow range, in the extreme case a unique result, indicate
a robust result. Thus, while LOOCV could be used to select the model, the
CV-process may indicate the robustness of the result.
Application on real data
Ten-fold and four-fold CV were applied on the CRC data[1] described in the
introduction. The resulting signature size bar diagrams are shown in Figure 5.1.
The tendency from Section 4.1.3 reappears here: Four-fold CV gives some larger
signatures than ten-fold CV, but there are also more cases of signatures with sizes
as small as three to five.
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Four-fold CV is not more stable, however, which is our main interest. In fact,
there are fewer peaks in the results of 4-fold CV than in 10-fold CV. The latter
favours the signatures of sizes 0-2, 8 and 10-12, whereas considerably many of
the 4-fold CV signatures are of other sizes.
LOOCV on the CRC data set results in a signature of size 2, i.e. if the chosen
λ had been smaller, the signature would contain more genes. The chosen value of
λ is actually not the parameter value that gives global minimum error: A profL1
run confirms this. The actual optimal λ gives a signature of size 10. It may be
that the K-fold CVs presented in Figure 5.1 are inclined to choose a suboptimal
λ which results in the very high bars at sizes 0-2 in the bar diagrams, see Section
6.3.1.
The effect of checking with profL1 may be great, as with the CRC data,
therefore it may be sensible to always verify the result of optL1 with profL1 to
be sure of the quality of the predicitve model.
5.2 Bootstrapping
There exists several methods for estimation of accuracy which may be applied to
survival data. One of these methods is the bootstrap[31].
The bootstrap constructs data sets based on the observed data set, which
consists of data for each observation: {(y1,x1, δ1), . . . , (yn,xn, δn)}, where yi is
the observed survival time for observation i, xi are the observed covariates (e.g.
one row in a gene expression matrix) and δi is the censoring indicator where
1 is an event, and 0 is a censoring. A bootstrap data set consists of n such
elements where each element is drawn randomly from the observed data set with
replacement.
The process of generating data sets and modelling is repeated numerous
times to describe the accuracy of the model trained on the real data. Efron
and Tibshirani[31] describe a Cox example based on leukemia remission times
in mice. The study is old, it consists of few observations and there is just one
covariate included in the regression model, so it is not directly applicable to the
CRC data[1]. However, the method to find the best βˆ is similar: the βˆ that
maximises the partial likelihood, as seen in (2.14), is chosen.
Now, how accurate is the estimation of βˆ? The partial likelihood is maximised
based on each new data set, and the choice of βˆ is taken note of. The resampling
and maximisation of the likelihood is repeated e.g. 1000 times, and we can make
a histogram for each βˆi. The form of the histogram will reflect the accuracy of
the value of βˆi and whether its distribution is right or left skewed, or unskewed.
Adjustment to penalised Cox regression should be straightforward: The pe-
nalised partial log-likelihood replaces the partial likelihood described in the gen-
eral bootstrapping case.
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Figure 5.1: 10- (top) and 4-fold (bottom) CV applied on CRC data.
optL1 was run 1000 times with the CRC data set as input. The sizes of the
resulting gene signatures are represented in these bar diagrams.
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Two methods for censor simulations are described in Efron and Tibshirani’s
paper[31]: One where the underlying distribution of the survival times is used,
and another where the censor indicator is ignored. They chose to ignore the
censoring indicator of each observation when resampling. For more detailed ex-
planation, see [31].
5.3 ROC curve
An ROC curve, such as described in Section 4.4, can be generated from prediction
models. If the points lie close to or below the diagonal, the models do not have
a good predictive value; in fact, a randomly chosen model would be a better
choice. Note that the complementary models of the models beneath the diagonal
give better predictions than the original model. When discussing genes as in the
examples of this thesis, instead of giving the proposed genes non-zero coefficients,
reduce them to zero and give the genes that were not chosen non-zero coefficients.
This model will lie on the opposite side of the diagonal and hence be of better
predictive value.
Visualisation of the chosen fit on real data by an ROC curve is a very difficult,
even impossible, task. To produce an ROC, the real relevant and irrelevant genes
must be known, but they are what is sought when applying Lasso and CV on
real data, and therefore unknown.
Chapter 6
Discussion
6.1 Summary and conclusions
The instability of K-fold CV is worrying, although potentially useful. Ideally, a
unique result would help by choosing one prognostic signature, but the range of
signatures suggested by K-fold CV can indicate the accuracy of the prediction.
It is not obvious that LOOCV should be used to select the final model. It
seems that a small K in K-fold CV increases the sizes of the signatures. This is
also the case when there are more observations available. It has been suggested
that 4-fold CV is the best choice for K-fold CV[30].
Increasing the number of observations is difficult. Simulations and common
sense show that having more observations usually generates more stable predictive
results and increases the predictive accuracy. In real life we must wait for more
cases of the condition in interest to appear or settle with the data set available.
As few as a hundred observations is common in survival studies. However, our
simulations underline that this is a low number for studies with large numbers of
covariates.
Properties of the survival data such as correlation and strength of the gene
effects are impossible to control in real data. However, it is important to be aware
that these properties affect the prediction result. E.g. if there is strong correlation
in some groups of genes, the Lasso will probably choose one or none genes in the
group to include in the predictive model. Depending on the application, it may
thus be useful to apply a different regularisation method.
There are several ways to investigate the accuracy and the predictive power.
Established methods include both ROC curves and bootstrapping. Bootstrapping
can describe how well we have estimated the values of the coefficients. The ROC
can describe the how well we have sorted real relevant genes and irrelevant genes
. Additionally, the method described in this thesis is to evaluate the range of
signatures suggested by Lasso and CV.
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6.2 Relation to other recent work
The reasoning for percentile-Lasso, described in Section 2.4, matches the results
in this thesis. An illustration in Robert’s paper[26] is similar to Figures 4.16 and
4.17. When n = 300, the line describing the number of correct genes given non-
zero coefficients is approximately constant. The line of incorrectly given non-zero
coefficients is decreasing. Thus, by choosing a larger λ than LOOCV’s choice, we
would mostly be left with fewer “incorrect” covariates and the same number of
“correct” covariates.
6.3 Discussion of results
6.3.1 My contributions
K-fold CV instability
Some properties, e.g. how Lasso picks one or none in a group of correlated
covariates[17], was known from earlier studies. However, the display of how the
K in K-fold affects the prediction result is new. There have been arguments for
choosing K=4[30], and other Ks for different types of data[32]; The main argu-
ment against choosing LOOCV is that every training set is nearly equal, because
only one observation is excluded every time, and therefore strongly depend on
each other. This may not train models well for a general scenario, but instead
makes it good for the specific data set. With K ≤ n/2 the differences between
the training sets are greater, so the model will be better suited for application on
other data[30].
In our case, where the CRC data[1] has been the motivation, the multiple
results with repeated 10-fold CVs have proven useful. Even though LOOCV
gives a unique result, K-fold CV when K ≤ n/2 provides useful information
about the certainty of the predictive model.
LOOCV sparsity
A large K of K-fold CV tends to give smaller signatures than small Ks, i.e.
LOOCV gives the fewest number of covariates with non-zero coefficients. It has
been discussed that LOOCV’s choice of λ usually is too small[26]. A larger λ
would give less covariates in the model, but mostly the “incorrect” genes would
be reduced. The number of “correct” genes would remain approximately the
same. Therefore, the increasing signature size when K decreases, i.e. it chooses
a smaller λ, encourages choosing K large.
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More observations
More observations usually give more accurate predictive results, which is well
known. My computations confirm this and show that increasing the number
of observations from 100 to 300 gives a much less varying result. In fact, the
instability when there are only 100 observations available is so apparent that it
may lead to a conclusion indicating that n = 100 observations are too few to
state an association between gene expression levels and survival.
Another effect of having more observations is that the suggested prognos-
tic signatures tend to be larger when n increases, and more observations are
thought to give better precision. Contrary to this observation, the previous sec-
tion “LOOCV sparsity” encourages us to choose a smaller signature. Both are
useful observations and underline the importance of being aware of the influence
of these factors.
Decreasing λ and reducing small coefficients to zero
The increasing signature sizes when n is large encourages the attempt to decrease
λ to include more covariates in the model, but then reduce the very small coef-
ficients to zero. This was attempted in this thesis and the result visualised by
an ROC curve. The curve was discouraging, but there may be a better way to
illustrate the effect of reducing coefficients to zero. It is known that Lasso and
CV do not always suggest the best λ[26], so the idea of an alternative to the
ordinary method is appealing.
The risk of choosing a suboptimal λ
Sveen et al.[1] gave a recipe of how to apply the R package penalized on CRC
data. They did not mention the risk that optL1 may choose a λ that gives a local
minimum error.
This risk is considerable as shown in this thesis and must be taken into con-
sideration when using the function. We can save time by not checking with a
function such as profL1, but time is usually not an issue in these cases.
Specific data set properties?
The motivation of this thesis was based on the CRC paper[1] and the question
“Is the method dependent on details of the data set?” was raised. Control of
simulation parameters such as correlation, number of observations and strength
of gene effects has shown that the instability is present for all types of data.
Therefore, the instability in the mentioned CRC paper is not unique, and cannot
be caused solely by properties of the CRC data.
76 CHAPTER 6. DISCUSSION
6.3.2 Weaknesses
Some computations, such as the information illustrated in the heat maps in Fig-
ures 4.1 and 4.6, where the variation of K-fold within one data set is shown, are
based on only one data set. This varying behaviour depends on different factors,
such as simulation parameters and the number of observations. Thus, the claim
of varying behaviour within one data set does not necessarily hold for all other
data sets.
As mentioned in the previous section, the risk of choosing a λ that gives a
local instead of the global minimum error is considerable, as shown in Section
4.5.1. This thesis has directed attention to this risk, but has ignored this scenario
in other calculations. Therefore, the other results may have looked somewhat
different if the λs had been corrected by e.g. profL1.
6.4 Further work
Several of the weaknesses listed in the previous section deserves attention, and
some questions have been left unanswered, such as: Will correcting for global
minimum error change the result of the CRC data, as discussed in Section 5.1?
and: In Section 4.1.3, the claim that more folds, i.e. larger K of K-fold, give
more sparse prognostic signatures was confirmed. The question “Will smaller ks
give more stable results?” was raised. These issues among others would have
been interesting to look further into.
The idea of reducing very small coefficients to zero has not been thoroughly
tested. A better way of illustrating the predictive results than an ROC curve
should be found and an alternative Lasso method may be developed in some way.
A better and more detailed mapping of the differences between penalized
and glmnet is missing. This thesis touches upon some of the differences, but no
proper documentation of e.g. what type of CV the two packages apply could be
found. Exactly what causes the different prediction result is therefore left out,
but should be looked further into, e.g. by comparison of source code.
Percentile-Lasso was presented based on information gathered from[26], pub-
lished online in September 2013, so it is fairly new. The proposed method of
increasing the penalty parameter λ is interesting and should be tested on data
such as the CRC data[1] discussed in this thesis.
An idea of a function of n to describe false positives when searching for the
real relevant genes was proposed in Section 4.2.2, i.e. how many irrelevant genes
are classified as relevant with non-zero coefficients. Finding such a function would
be useful when deciding whether there are enough observations available to draw
a conclusion.
All the factors that affect Lasso and CV stability presented in this thesis have
been tested more or less separately. A combination of factors, e.g. how varying
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correlation affects the differences between K-fold CV with different Ks, is also
of interest. Especially the effect of always using the correct (global) penalty
parameter λ is an interesting topic for further studies.
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Appendix A
A.1 Average signature sizes
Here follows the average signature sizes for all 100 data sets from the calculations
in Section 4.1.3. The columns represent the folds, named in the first row. The
rows represent every data set.
"100" "25" "20" "10" "5" "4" "3"
0 0 0 1.2 9.1 7.3 14.2
11 10.8 12.9 14.4 17 19.6 20.4
6 6.4 6.3 9.6 21.6 24.7 22.7
6 11.8 14.5 15.9 20.8 19.2 24.2
18 17.9 19.5 17.4 22.5 19.6 21.6
11 10 10.5 10.9 13.8 12.1 16.6
17 18.1 18.2 19.7 21.9 24.2 25.8
6 5.4 9.6 9.8 10.6 16.2 18.5
9 9.9 11.8 15.2 15.8 18.9 20.2
2 3.1 3 3.1 5.4 6.5 6.8
10 12.9 14.1 14.1 18.8 22 22.8
0 7.7 8.2 8.7 16.6 18.5 27.2
6 6.9 8.3 11.5 15.1 20.1 25.8
8 8.9 9.1 9.8 12 18.2 18.2
16 20.1 20.1 20.3 22.7 26.1 28.7
0 0.2 0.2 0 3.1 3 3.7
7 8 8.9 10.7 14.1 10.3 15.1
11 10.8 11.3 11.2 13.6 18.4 18.8
10 10.4 10.8 12 20 21.2 24.6
22 21.1 21.5 22.6 20.5 23 24.6
7 8.5 9.2 11.8 14.6 11.9 17.5
9 9.7 10 12.7 14.6 17.3 21.5
16 13.3 14.7 13.2 10.4 9 7.9
7 7.5 8.1 13 21.6 16.7 18.5
13 13.2 13.6 13.6 11.8 12.9 15.1
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14 11.2 14.2 11.9 16.1 12.2 24.5
13 9.1 10.5 10.1 12.9 15.2 12
0 0 0.1 3.8 3.5 4.7 11.3
12 17.4 19.7 20.1 21.3 20.2 20.1
11 14.5 15.4 15.9 16.9 20.9 19.7
21 9.5 9.3 13.5 13.5 4.6 10.4
12 11.7 11.5 12 19.2 21.5 30
12 12 13.5 13.4 12 9.3 19.7
5 7.3 8.2 13.5 15.6 17.1 21.8
11 7.8 8.6 10 8 10.9 14.5
10 10.4 11.1 10.9 13.7 17.9 25.5
8 11.2 13.6 24.1 29.9 29.6 26.1
7 8 8.6 12.7 10.9 11.7 17
18 19.8 17.5 19.3 17.1 20.4 22.8
3 6.2 6.4 6.1 12.1 12.8 10.3
18 19.5 20.1 20.4 21.5 23.5 22.7
7 5.8 6 8.3 15.8 19 14.9
22 21.7 20.8 20.9 19 22.3 22.7
25 21.9 19.2 17.6 15.3 14.9 12
14 14.4 14.3 15.7 20.5 24.9 26.7
18 18.6 18.9 16.7 13.9 17.2 13.6
8 10.1 11.2 12.4 16.1 19.6 19.6
16 16.5 15.9 18.9 18.1 21.4 21.8
15 16.6 16.6 16.4 16.8 18.4 22.6
0 6.9 6.8 14.5 16.3 18 21.9
6 10.7 10.4 14 16.6 15.4 20.1
9 9.3 11.1 10.5 15.6 21.4 21
13 13.7 13.9 13.8 20.1 20.6 20
10 11.3 12 10.8 15.6 12 13.7
17 16.2 15.7 15.9 18.2 18.2 20.8
1 1.3 1.6 5.3 11.6 14.8 14.7
3 5.1 3.2 6.1 8.6 8.7 9.6
21 20.2 20.3 21.2 21 20.8 20.6
4 5.3 5.2 7.7 15.3 18.2 17.8
7 7.5 8.7 11.5 14.9 16.8 16.2
1 1.9 2.2 2 3.6 4.4 6.5
1 6.5 4 6 9.8 16.7 19.4
11 9.9 7.8 8.4 9.2 6.7 12.7
0 0.4 0.6 4 8.4 6.8 12.9
3 9 8.5 10.9 15.5 17.2 14
17 18.3 19.4 19.6 20.4 22.2 23.1
12 12.8 14.1 14.3 17 19.5 20.6
19 20.6 21.4 23.3 23.6 25.4 27.2
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14 14 12.9 11.7 13.1 14.7 14.9
0 3.8 3.1 5.4 12.8 10.2 11.7
4 5.9 4.6 8.3 10.7 11.9 8.5
12 11.9 11.4 10.2 14 9.6 14.6
15 14.6 12.9 15.8 19.1 19.6 21.1
11 11 10.1 11.1 12.9 10.7 15.9
12 10.8 10.8 11.4 15.1 14.2 18.6
11 9.4 10.8 10 11.5 9.8 14.9
10 12.7 12.4 14.2 18 17.7 19
3 1.9 4.3 2.5 7 8.1 8.1
1 1.9 1.8 3.2 9.9 9.8 11.3
22 23 23.7 21.5 24.6 23.1 22
9 12 11.9 14.3 19.7 22.4 25.4
13 14.1 14 13.9 12.6 14.7 18.7
10 17.2 18.3 22.5 26.4 26.8 28.4
2 2 2 2.6 5.2 8.8 15.3
12 12.3 14.2 13.5 17.6 17 18.6
16 20.1 20.2 22 24.3 25.3 30.2
7 8.3 9 9.1 13.1 13.5 16.1
10 18.9 20.4 23 22.9 26.9 29.9
6 6.9 7.5 11.7 15.1 18 25.5
17 14.8 12.9 11.3 9.2 9.2 13.9
13 13.1 13.2 13.5 15.3 16.1 15.6
4 4.7 6.4 3.8 6.8 8.5 8.1
7 8.9 7.8 11.2 11.8 14.1 19.4
15 14.1 14.3 14.9 15 19 16
11 9.6 11.3 8.1 9.3 17.8 17
0 0 0 0 3.7 2 5.4
5 5.7 6.5 9.6 8.3 11.9 11.9
24 23.1 17.7 10.3 10.2 5.9 10.2
19 9.5 9.3 6.2 5.7 12.5 12.2
1 1.1 1.5 3 5.2 6 13.1
A.2 Larger illustrations
Larger illustrations of some of the figures in the thesis are shown here, in Figures
A.1-A.11.
86 APPENDIX A.
Figure A.1: One dataset, 5-, 4- and 3-fold CV. A closer look at part of
Figure 4.3.
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Figure A.2: One dataset, 20-, 10- and 5-fold CV. A closer look at part of
Figure 4.3.
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Figure A.3: One dataset, LOO, 25- and 20-fold CV. A closer look at part
of Figure 4.3.
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Figure A.4: 100 observations, LOOCV. Larger version of left hand side of
Figure 4.4, showing all 1000 genes.
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Figure A.5: 100 observations, LOOCV. Larger version of right hand side
of Figure 4.4, showing just the 200 first genes.
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Figure A.6: 300 observations, LOOCV. Larger version of the left hand side
of Figure 4.5, showing all 1000 genes.
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Figure A.7: 300 observations, LOOCV. Larger version of the right hand
side of Figure 4.5, showing just the 200 first genes.
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Figure A.8: 500 observations, LOOCV. Larger version of left hand side of
Figure 4.7.
94 APPENDIX A.
Figure A.9: 500 observations, LOOCV. Larger version of right hand side
of Figure 4.7.
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Figure A.10: Glmnet, n=100 observations. From Figure 4.18, left hand
side.
A.3 More examples
More examples of some of the computations shown in Figures in the thesis are
shown here, in Figures A.12-A.16.
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Figure A.11: Glmnet, n=300 observations. From Figure 4.18, right hand
side.
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Figure A.12: One dataset, different folds. As in Figure 4.3, but a new data
set.
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Figure A.13: One dataset, different folds. As in Figure 4.3, but a new data
set.
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Figure A.14: Checking for global minimum error. Like Figure 4.15, but
with a new data set.
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Figure A.15: Checking for global minimum error. Like Figure 4.15, but
with a new data set.
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Figure A.16: Comparison of glmnet and penalized. Zoom out of Figure
4.19.
